WD
MCID: WLS001
MIFTS: 72

Wilson Disease (WD) malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Liver diseases, Nephrological diseases, Metabolic diseases, Gastrointestinal diseases

Aliases & Classifications for Wilson Disease

About this section

Aliases & Descriptions for Wilson Disease:

Name: Wilson Disease 52 35 11 71 23 48 24 25 49 54 70 12 50 38 13
Hepatolenticular Degeneration 11 23 48 24 54 70 39 68
Wilson's Disease 11 25 27 13
Wd 48 25 70
Hepatolenticular Degeneration Syndrome 25
 
Westphal-Strumpell Syndrome 11
Cerebral Pseudosclerosis 11
Westphal Pseudosclerosis 11
Copper Storage Disease 25
Wnd 48

Characteristics:

Orphanet epidemiological data:

54
wilson disease:
Inheritance: Autosomal recessive; Prevalence: 1-9/100000 (Worldwide),1-9/100000 (Europe),1-9/100000 (France),1-9/1000000 (Italy),1-5/10000 (Japan),1-5/10000,1-5/10000 (Ireland),1-9/100000 (Germany); Age of onset: Childhood

HPO:

64
wilson disease:
Inheritance: autosomal recessive inheritance

Classifications:



External Ids:

OMIM52 277900
Disease Ontology11 DOID:893
ICD1030 E83.01
MeSH39 D006527
NCIt45 C84756
Orphanet54 ORPHA905
MESH via Orphanet40 D006527
UMLS via Orphanet69 C0019202
ICD10 via Orphanet31 E83.0
MedGen37 C0019202

Summaries for Wilson Disease

About this section
NINDS:49 Wilson disease (WD) is a rare inherited disorder of copper metabolism in which excessive amounts of copper accumulate in the body. The buildup of copper leads to damage in the liver, brain, and eyes. Although copper accumulation begins at birth, symptoms of the disorder only appear later in life. The most characteristic sign of WD is the Kayser-Fleisher ring – a rusty brown ring around the cornea of the eye that can best be viewed using an ophthalmologist’s slit lamp. The primary consequence for most individuals with WD is liver disease, appearing in late childhood or early adolescence as acute hepatitis, liver failure, or progressive chronic liver disease in the form of chronic active hepatitis or cirrhosis of the liver. In others, the first symptoms are neurological, occur later in adulthood, and commonly include slurred speech (dysarthria), difficulty swallowing (dysphagia), and drooling. Other symptoms may include tremor of the head, arms, or legs; impaired muscle tone, and sustained muscle contractions that produce abnormal postures, twisting, and repetitive movements (dystonia); and slowness of movements (bradykinesia). Individuals may also experience clumsiness (ataxia) and loss of fine motor skills. One-third of individuals with WD will also experience psychiatric symptoms such as an abrupt personality change, bizarre and inappropriate behavior, depression accompanied by suicidal thoughts, neurosis, or psychosis. WD is diagnosed with tests that measure the amount of copper in the blood, urine, and liver.

MalaCards based summary: Wilson Disease, also known as hepatolenticular degeneration, is related to liver disease and suprabulbar paresis, congenital, and has symptoms including abdominal pain, abdominal pain and back pain. An important gene associated with Wilson Disease is ATP7B (ATPase Copper Transporting Beta), and among its related pathways are Platinum drug resistance and Platinum Pathway, Pharmacokinetics/Pharmacodynamics. The drugs trientine hydrochloride and trientine have been mentioned in the context of this disorder. Affiliated tissues include liver, brain and eye, and related mouse phenotypes are pigmentation and liver/biliary system.

NIH Rare Diseases:48 Wilson disease is a rare inherited disorder that is characterized by the accumulation of copper in the body. because high levels of copper are toxic to tissues and organs, this buildup can lead to damage of the liver, brain and eyes. signs and symptoms of wilson disease include chronic liver disease, central nervous system abnormalities, and psychiatric (mental health-related) disturbances. it is caused by a mutation of the atp7b gene and is inherited in an autosomal recessive manner. although there is no cure for wilson disease, therapies exist that aim to reduce or control the amount of copper that accumulates in the body. last updated: 2/5/2015

UniProtKB/Swiss-Prot:70 Wilson disease: An autosomal recessive disorder of copper metabolism in which copper cannot be incorporated into ceruloplasmin in liver, and cannot be excreted from the liver into the bile. Copper accumulates in the liver and subsequently in the brain and kidney. The disease is characterized by neurologic manifestations and signs of cirrhosis.

MedlinePlus:38 Wilson disease is a rare inherited disorder that prevents your body from getting rid of extra copper. you need a small amount of copper from food to stay healthy. too much copper is poisonous. normally, your liver releases extra copper into bile, a digestive fluid. with wilson disease, the copper builds up in your liver, and it releases the copper directly into your bloodstream. this can cause damage to your brain, kidneys, and eyes. wilson disease is present at birth, but symptoms usually start between ages 5 and 35. it first attacks the liver, the central nervous system or both. the most characteristic sign is a rusty brown ring around the cornea of the eye. a physical exam and laboratory tests can diagnose it. treatment is with drugs to remove the extra copper from your body. you need to take medicine and follow a low-copper diet for the rest of your life. don't eat shellfish or liver, as these foods may contain high levels of copper. at the beginning of treatment, you'll also need to avoid chocolate, mushrooms, and nuts. have your drinking water checked for copper content and don't take multivitamins that contain copper. with early detection and proper treatment, you can enjoy good health. nih: national institute of diabetes and digestive and kidney diseases

Genetics Home Reference:25 Wilson disease is an inherited disorder in which excessive amounts of copper accumulate in the body, particularly in the liver, brain, and eyes. The signs and symptoms of Wilson disease usually first appear between the ages of 6 and 45, but they most often begin during the teenage years. The features of this condition include a combination of liver disease and neurological and psychiatric problems.

OMIM:52 Wilson disease is an autosomal recessive disorder characterized by dramatic build-up of intracellular hepatic copper... (277900) more...

Wikipedia:71 Wilson\'s disease is a genetic disorder in which copper builds up in the body. Symptoms are typically... more...

GeneReviews for NBK1512

Related Diseases for Wilson Disease

About this section

Diseases related to Wilson Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 112)
idRelated DiseaseScoreTop Affiliating Genes
1liver disease11.1
2suprabulbar paresis, congenital11.0
3warty dyskeratoma10.9
4wolman disease10.8
5hepatitis10.2
6extrahepatic bile duct leiomyoma10.2CP, HFE
7ectodermal dysplasia 1, hypohidrotic, x-linked10.2ATP7A, LOX
8dermatoleukodystrophy10.1HFE, TF
9ehlers-danlos syndrome, type viib10.1ATP7A, ATP7B
10hypersensitivity syndrome, carbamazepine-induced10.1ALB, HFE
11tmem216-related meckel syndrome10.1HFE, TF
12acute liver failure10.1
13neurological manifestations of pompe disease10.1ALB, CAT, CP
14post-thrombotic syndrome10.1CP, HFE, TF
15facial paresis, hereditary congenital, 110.1CP, HFE, TF
16harp syndrome10.0HFE, TF
17male genital organ stricture10.0ALB, TF
18posterior uveal melanoma10.0ATP7A, ATP7B, HFE, TF
19hair disease10.0
20aminoaciduria10.0
21nasu-hakola disease10.0ATP7B, CP, HFE, TF
22central nervous system leiomyoma10.0ALB, CP, TF
23coronary artery dissection, spontaneous10.0ALB, TF
24spinal muscular atrophy, distal, x-linked 310.0ATOX1, ATP7A, ATP7B, CP, LOX
25epileptic encephalopathy, early infantile, 139.9CP, TF
26menkes disease9.9
27esophageal leukoplakia9.9ATP7A, ATP7B, CP, HFE, TF
28rosacea9.9ALB, CP, GPT
29isolated growth hormone deficiency9.9ALB, CP, GPT
30lung cancer9.9
31bile duct cystadenocarcinoma9.9ALB, GPT
32hepatocellular carcinoma9.9
33noninfectious dermatoses of eyelid9.8ALB, GPT, HFE
34alopecia9.8DRD2, GPT, TF
35sarcoma9.8
36female infertility of uterine origin9.8ALB, GPT, TF
37retinal arterial macroaneurysm with supravalvular pulmonic stenosis9.8ALB, GPT, TF
38retinoblastoma9.7
39hemochromatosis9.7
40neuropathy9.7
41neuronal ceroid-lipofuscinoses9.7ALB, CAT, CP, HFE, TF
42colorectal cancer9.7
43melioidosis9.7
44squamous cell carcinoma, head and neck9.7
45colorectal adenoma9.7
46renal oncocytoma9.7
47tongue squamous cell carcinoma9.7
48polycystic kidney disease9.7
49hepatosplenic t-cell lymphoma9.7
50bladder sarcoma9.7ALB, CP, GPT, TF

Graphical network of the top 20 diseases related to Wilson Disease:



Diseases related to wilson disease

Symptoms & Phenotypes for Wilson Disease

About this section

Symptoms by clinical synopsis from OMIM:

277900

Clinical features from OMIM:

277900

Human phenotypes related to Wilson Disease:

 54 64 (show all 61)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 abnormality of the menstrual cycle64 54 Very frequent (99-80%) HP:0000140
2 depression64 54 Very frequent (99-80%) HP:0000716
3 aggressive behavior64 54 Very frequent (99-80%) HP:0000718
4 jaundice64 54 Very frequent (99-80%) HP:0000952
5 bruising susceptibility64 54 Very frequent (99-80%) HP:0000978
6 pruritus64 54 Very frequent (99-80%) HP:0000989
7 abnormality of the hand64 54 Very frequent (99-80%) HP:0001155
8 intellectual disability64 54 Very frequent (99-80%) HP:0001249
9 dysarthria64 54 Very frequent (99-80%) HP:0001260
10 arthritis64 54 Very frequent (99-80%) HP:0001369
11 joint swelling64 54 Very frequent (99-80%) HP:0001386
12 cirrhosis64 54 Very frequent (99-80%) HP:0001394
13 hepatic steatosis64 54 Very frequent (99-80%) HP:0001397
14 failure to thrive64 54 Very frequent (99-80%) HP:0001508
15 splenomegaly64 54 Very frequent (99-80%) HP:0001744
16 weight loss64 54 Very frequent (99-80%) HP:0001824
17 thrombocytopenia64 54 Very frequent (99-80%) HP:0001873
18 anemia64 54 Very frequent (99-80%) HP:0001903
19 hepatomegaly64 54 Very frequent (99-80%) HP:0002240
20 clumsiness64 54 Very frequent (99-80%) HP:0002312
21 difficulty walking64 54 Very frequent (99-80%) HP:0002355
22 bone pain64 54 Very frequent (99-80%) HP:0002653
23 pathologic fracture64 54 Very frequent (99-80%) HP:0002756
24 arthralgia64 54 Very frequent (99-80%) HP:0002829
25 elevated hepatic transaminases64 54 Very frequent (99-80%) HP:0002910
26 back pain64 54 Very frequent (99-80%) HP:0003418
27 increased body weight64 54 Very frequent (99-80%) HP:0004324
28 acute hepatic failure64 54 Very frequent (99-80%) HP:0006554
29 proximal muscle weakness in lower limbs64 54 Very frequent (99-80%) HP:0008994
30 hepatitis54 Very frequent (99-80%)
31 hypersexuality64 54 Very frequent (99-80%) HP:0030214
32 kayser-fleischer ring64 54 Very frequent (99-80%) HP:0200032
33 acute hepatitis64 54 Very frequent (99-80%) HP:0200119
34 proteinuria64 HP:0000093
35 renal tubular dysfunction64 HP:0000124
36 dementia64 HP:0000726
37 personality changes64 HP:0000751
38 nephrolithiasis64 HP:0000787
39 hypoparathyroidism64 HP:0000829
40 chondrocalcinosis64 HP:0000934
41 osteoporosis64 HP:0000939
42 coma64 HP:0001259
43 polyneuropathy64 HP:0001271
44 dystonia64 HP:0001332
45 tremor64 HP:0001337
46 joint hypermobility64 HP:0001382
47 hepatic failure64 HP:0001399
48 hemolytic anemia64 HP:0001878
49 dysphagia64 HP:0002015
50 esophageal varix64 HP:0002040
51 hypercalciuria64 HP:0002150
52 poor motor coordination64 HP:0002275
53 drooling64 HP:0002307
54 osteomalacia64 HP:0002749
55 osteoarthritis64 HP:0002758
56 glycosuria64 HP:0003076
57 hyperphosphaturia64 HP:0003109
58 aminoaciduria64 HP:0003355
59 mixed demyelinating and axonal polyneuropathy64 HP:0007327
60 high nonceruloplasmin-bound serum copper64 HP:0010838
61 atypical or prolonged hepatitis64 HP:0200122

UMLS symptoms related to Wilson Disease:


abdominal pain, back pain, constipation, diarrhea, dyspepsia, headache, heartburn, icterus, nausea and vomiting, pain, sciatica, seizures, syncope, tremor, chronic pain, personality changes, vertigo/dizziness, gastrointestinal gas, sleeplessness

MGI Mouse Phenotypes related to Wilson Disease according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011868.6ATOX1, ATP7A, ATP7B, CP, DRD2, SLC31A1
2MP:00053708.2ALB, ATOX1, ATP7A, ATP7B, COMMD1, CP
3MP:00107686.6ALB, ATOX1, ATP7A, ATP7B, CAT, COMMD1
4MP:00053766.5ALB, ATOX1, ATP7A, ATP7B, CAT, COMMD1

Drugs & Therapeutics for Wilson Disease

About this section

Drugs for Wilson Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 615)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Aspirinapproved, vet_approvedPhase 4, Phase 3115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
2
Histamineapproved, investigationalPhase 4, Phase 3, Phase 2105075614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-(4-imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
4-imidazoleethylamine
5-Imidazoleethylamine
5-imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminoethylglyoxaline
beta-aminoethylimidazole
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
3
SimvastatinapprovedPhase 4, Phase 351979902-63-954454
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Bio-0672
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
CID54454
CPD000718785
Cholestat
Coledis
Colemin
Corolin
D00434
D019821
DRG-0320
Denan
DivK1c_006991
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
KS-1113
Kolestevan
L 644128-000U
LS-46264
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
MK 0733
MK 733
MK-0733
MK-733
MK733
MLS001304029
MLS001333077
MLS001333078
 
MLS002154038
Medipo
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
Nivelipol
Nor-Vastina
Pantok
Pepstatin
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Prestwick_171
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
SMR000718785
SPBio_001881
SPBio_002830
SPECTRUM1504236
STK801938
Simcor
Simovil
Simvast CR
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [USAN:INN:BAN]
Simvastatin [Usan:Ban:Inn]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SpecPlus_000895
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Spectrum_001717
Statin
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
nchembio790-comp16
simvastatin
4
Etanerceptapproved, investigationalPhase 4403185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
5
Celecoxibapproved, investigationalPhase 4, Phase 3444169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
6
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
7
IbuprofenapprovedPhase 451815687-27-13672
Synonyms:
(4-isobutylphenyl)-α-methylacetic acid
(RS)-ibuprofen
(±)-2-(p-isobutylphenyl)propionic acid
(±)-ibuprofen
(±)-p-isobutylhydratropic acid
(±)-α-methyl-4-(2-methylpropyl)benzeneacetic acid
139466-08-3
15687-27-1
2-(4-isobutylphenyl)propanoic acid
4-isobutylhydratropic acid
58560-75-1
AC-11312
AC1L1GGE
AC1Q1P84
AC1Q1P85
ACHES-N-PAIN
ARONIS23835
Act-3
Actiprofen
Adex 200
Adran
Advil
Advil (TN)
Advil Liqui-Gels
Ak+C2278tren
Alaxan
Algofen
Am-Fam 400
Amelior
Amersol
Amibufen
Anafen
Anco
Andran
Anflagen
Antagil
Antalfene
Antarene
Antiflam
Apo-Ibuprofen
Apsifen
Apsifen-F
Artofen
Artril
Artril 300
BB_SC-1358
BIDD:GT0050
BRN 2049713
Balkaprofen
Betaprofen
Bloom
Bluton
Brofen
Brufanic
Brufen
Brufen 400
Bruflam
Brufort
Buburone
Bufeno
Bufigen
Bukrefen
Bupron
Buracaps
Burana
Butylenin
C01588
C13H18O2
CCRIS 3223
CHEBI:5855
CHEMBL521
CID3672
CPD000058184
Cap-Profen
Carol
Cesra
Children's Advil
Children's Elixsure
Children's Ibuprofen
Children's Motrin
Citalgan
Cobo
Codral
Combiflam
Cunil
D00126
D007052
DB01050
DOLO PUREN
Daiprophen
Dalsy
Dansida
Deep Relief
Dentigoa
Dibufen
Dignoflex
Dolgin
Dolgirid
Dolgit
Dolibu
Dolmaral
Dolo-Dolgit
Dolocyl
Dolofen
Dolofen-F
Dolofin
Dolofort
Dologel
Dolomax
Doloren
Dolormin
Doltibil
Dolven
Donjust B
Dorival
Drin
Duafen
Duobrus
Dura-Ibu
Duralbuprofen
Dysdolen
EU-0100691
Easifon
Ebufac
Emflam
Emflam-200
Emodin
Epobron
Eputex
Ergix
Esprenit
Exneural
Faspic
Femadon
Femafen
Femapirin
Femidol
Fenbid
Fenbid Spansule
Fendol
Fenspan
Fibraflex
Gelufene
Gofen
Grefen
Gynofug
HMS1920F15
HMS2089P05
HMS2091N03
HMS502M09
HSDB 3099
Haltran
I 4883
I01-7039
I0415
I4883_SIGMA
I7905_SIAL
IB-100
IDI1_000887
IP 82
IP-82
IP82
Ibol
Ibren
Ibu
Ibu-Attritin
Ibu-Slo
Ibu-Tab
Ibu-Tab 200
Ibu-slo
Ibu-slow
Ibubest
Ibubeta
Ibucasen
Ibudol
Ibudolor
 
Ibufen
Ibuflamar
Ibufug
Ibugel
Ibugen
Ibugesic
Ibuhexal
Ibulagic
Ibular
Ibulav
Ibuleve
Ibulgan
Ibumed
Ibumerck
Ibumetin
Ibupirac
Ibuprin
Ibuprocin
Ibuprofene
Ibuprofeno
Ibuprofenum
Ibuprohm
Ibuprophen
Ibusal
Ibutid
Ifen
Inabrin
Inflam
Inoven
Ipren
Irfen
Isodol
Jenaprofen
Junifen
Junior Strength Advil
Junior Strength Ibuprofen
Junior Strength Motrin
KBio1_000887
KBio2_001329
KBio2_003897
KBio2_006465
KBio3_001390
Kesan
Kratalgin
LS-7454
Lamidon
Lebrufen
Librofem
Lidifen
Liptan
Lopane
MLS000069733
MLS001146965
Malafene
Manypren
Medipren
Melfen
Mensoton
Midol
Midol 200
Moment
Motrin
Motrin (TN)
Motrin IB
Mynosedin
NCI60_002065
NINDS_000887
NSC 256857
NSC256857
Nagifen-D
Napacetin
Narfen
Neo-Helvagit
Neo-Mindol
NeoProfen
Neobrufen
Nerofen
Noalgil
Nobafon
Nobfelon
Nobfen
Nobgen
Noritis
Norton
Novadol
Novo-Profen
Novogent
Novogent N
Novoprofen
Nuprilan
Nuprin
Nurofen
Optifen
Opturem
Oralfene
Ostarin
Ostofen
Ozonol
P-Isobutylhydratropic Acid
Paduden
Panafen
Pantrop
Para-Isobutylhydratropic Acid
Paxofen
Pedia-Profen
PediaProfen
Pediaprofen
Pediatric Advil
Perofen
Proartinal
Profen
Proflex
Provon
Quadrax
R.D. 13621
RD 13621
Rafen
Ranofen
Rebugen
Relcofen
Rhinadvil
Rofen
Roidenin
Rufen
Rufin
Rupan
SAM002264619
SMR000058184
SPBio_000178
STK177358
Sadefen
Salivia
Salprofen
Seclodin
Sednafen
Seklodin
Seskafen
Siyafen
Solpaflex
Solufen
Stelar
Sugafen
Suprafen
Suspren
Syntofene
TL8001184
Tab-Profen
Tabalon
Tabalon 400
Tatanal
Tempil
Tofen
Togal N
Tonal
Trendar
U 18573
U-18,573
U-18573
UCB 79171
Unipron
Upfen
Uprofen
Urem
VUFB 9649
Zafen
Zofen
alpha-(4-Isobutylphenyl)propionate
alpha-(4-Isobutylphenyl)propionic acid
alpha-p-Isobutylphenylpropionate
alpha-p-Isobutylphenylpropionic acid
ibuprofen
p-Isobutyl-2-phenylpropionate
p-Isobutyl-2-phenylpropionic acid
p-Isobutylhydratropate
p-Isobutylhydratropic acid
α-(4-isobutylphenyl)propionic acid
α-(p-isobutylphenyl)propionic acid
8
Rivastigmineapproved, investigationalPhase 483123441-03-277991
Synonyms:
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
123441-03-2
3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
AB1004572
AC1L2U92
BIDD:GT0316
C11766
CHEMBL636
CID77991
Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
D03822
DB00989
ENA 713 free base
 
Ena 713 Free Base
Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
Exelon
Exelon Patch
HMS2089H18
I06-2037
LS-172571
MolPort-003-666-662
NCGC00167531-01
Rivastigmine (JAN/USAN/INN)
Rivastigmine Hydrogen Tartrate
Rivastigmine [USAN:INN]
Rivastigmine hydrogen tartrate
SDZ 212-713
UNII-PKI06M3IW0
[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
rivastigmine
9
Insulin GlargineapprovedPhase 4, Phase 3528160337-95-1
Synonyms:
 
Insulin Glargine (rDNA origin)
Insulin glargine recombinant
10
SevelamerapprovedPhase 47452757-95-6, 152751-57-03085017
Synonyms:
Sevelamer
 
Sevelamero
Sevelamerum
Sévélamer
11
Prednisoneapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
12
Naproxenapproved, vet_approvedPhase 4, Phase 325722204-53-11302, 156391
Synonyms:
(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-(S)-6-Methoxy-α-methyl-2-naphthaleneacetic acid
(+)-(S)-Naproxen
(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionic acid
(+)-2-(Methoxy-2-naphthyl)-propionsaeure
(+)-2-(Methoxy-2-naphthyl)-propionsaeure [German]
(+)-2-(Methoxy-2-naphthyl)-propionsäure
(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(+)-Naproxen
(+)NAPROXEN
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid
(S)-()-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-()-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-(+)-Naproxen
(S)-2-(6-Methoxy-2-naphthyl)propanoic acid
(S)-2-(6-Methoxy-2-naphthyl)propionic acid
(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid
(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid
(S)-Naproxen
2-(6-Methoxy-2-naphthyl)propionic acid
2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- (8CI)
22204-53-1
284785_ALDRICH
46482_FLUKA
46482_RIEDEL
65126_FLUKA
AC-1363
AC1L4G3X
AC1Q4ET9
AC1Q4F4H
AC1Q4F4I
ARONIS24306
Acusprain
Aleve
Anaprox
Anax
Anexopen
Apo-Napro-NA
Apo-Naproxen
Apronax
Artagen
Arthrisil
Artrixen
Artroxen
Atiflan
Axer
BIDD:GT0062
BRD-K59197931-001-02-9
BRD-K59197931-236-09-6
BSPBio_002067
Bipronyl
Bonyl
CAS-22204-53-1
CCRIS 5265
CG 3117
CHEBI:7476
CHEMBL154
CID156391
Calosen
Clinosyn
Congex
D-Naproxen
DB08298
DL Naproxen
DL-Naproxen
Danaprox
Daprox
Diocodal
DivK1c_000242
Duk
Dysmenalgit
Dysmenalgit N
EINECS 244-838-7
Ec-Naprosyn
Equiproxen
Equiproxen (Veterinary)
FT-0082415
Flanax Forte
Flexen
Flexipen
Floginax
Fuxen
Genoxen
HMS1920P13
HMS2089N21
HMS2091H12
HMS500M04
HSDB 3369
Headlon
IDI1_000242
InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
KBio1_000242
KBio2_001457
KBio2_004025
KBio2_006593
KBio3_001567
KBioGR_000597
KBioSS_001457
LS-124738
 
Laraflex
Lefaine
Leniartil
Lopac0_000792
M1021
Methoxypropiocin
MolPort-000-145-960
N8280_SIAL
NAPROXEN
NCGC00016759-01
NCGC00021127-01
NCGC00161591-01
NINDS_000242
NPS
Nafasol
Naixan
Nalyxan
Napflam
Napmel
Naposin
Napratec
Naprelan
Napren
Napren E
Naprius
Naprolag
Naprontag
Naprosin
Naprosyn LLE
Naprosyn LLE Forte
Naprosyne
Naproxen
Naproxen Sodium
Naproxen [USAN:BAN:INN:JAN]
Naproxene
Naproxene [INN-French]
Naproxeno
Naproxeno [INN-Spanish]
Naproxenum
Naproxenum [INN-Latin]
Naproxi 250
Naproxi 500
Naproxène
Napxen
Narma
Narocin
Naxen
Naxen F
Naxopren
Naxyn
Naxyn 250
Naxyn 500
Noflam
Novonaprox
Nycopren
Opipramol
Patxen
Prafena
Prestwick0_000791
Prestwick1_000791
Prestwick2_000791
Prestwick_349
Prexan
Priaxen
Pronaxen
Proxen LE
Proxen LLE
RS 3540
RS-3540
Rahsen
Reuxen
Rheumaflex
Roxen
SPBio_000966
SPBio_002861
SPECTRUM1500425
SR-01000075977-3
STOCK1N-50633
Saritilron
Sinartrin
Sinton
Soproxen
Spectrum2_001043
Spectrum3_000514
Spectrum4_000069
Spectrum5_001327
Spectrum_000977
Sutolin
Sutony
TL8003659
Tohexen
Traumox
U-Ritis
UNII-57Y76R9ATQ
UPCMLD-DP001
UPCMLD-DP001:001
Velsay
Veradol
Vinsen
Xenar
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure
d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German]
d-2-(6-Methoxy-2-naphthyl)propionic acid
d-Naproxen
13
BupropionapprovedPhase 432934841-39-9, 34911-55-2444
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
AMFEBUTAMONE HCl
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
Amfebutamonum
Amfebutamonum [INN-Latin]
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion Hcl
Bupropion SR
Bupropion [INN:BAN]
Bupropion hydrocloride
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
DivK1c_007050
Elont
 
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
LS-122817
Lopac0_000166
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
Spectrum_001663
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Zyban
alpha-(tert-butylamino)-m-chloropropiophenone
amfebutamonum
bupropion
14
MianserinapprovedPhase 45224219-97-44184
Synonyms:
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
21535-47-7 (mono-hydrochloride)
24219-97-4
AC-631
AC1L1HLP
BPBio1_000064
BPBio1_000331
BRD-A19661776-001-01-5
BRD-A19661776-003-05-2
BRN 0755346
BSPBio_000058
BSPBio_003511
Biomol-NT_000135
Bolvidon
C18H20N2
CHEBI:51137
CHEMBL6437
CID4184
D08216
DB06148
DivK1c_000844
EINECS 246-088-6
HMS2089A04
HSDB 7182
IDI1_000844
KBio1_000844
KBio2_002301
KBio2_004869
KBio2_007437
KBio3_003016
KBioGR_001820
KBioSS_002303
L000736
LS-61197
Lopac0_000744
 
Mianserin (INN)
Mianserin Monohydrochloride
Mianserin [INN:BAN]
Mianserina
Mianserina [INN-Spanish]
Mianserina [inn-spanish]
Mianserine
Mianserine [INN-French]
Mianserine [inn-french]
Mianserinum
Mianserinum [INN-Latin]
Mianserinum [inn-latin]
Mianseryna
Mianseryna [Polish]
Mianseryna [polish]
MolPort-003-849-215
NCGC00015656-09
NCGC00024926-03
NCGC00024926-04
NINDS_000844
Norval
Oprea1_703627
PDSP1_001532
PDSP2_001516
Prestwick0_000099
Prestwick1_000099
Prestwick2_000099
Prestwick3_000099
SPBio_000986
SPBio_001997
Spectrum2_001203
Spectrum3_001836
Spectrum4_001260
Spectrum5_001772
Spectrum_001810
Tolvan
Tolvon
Tolvon (TN)
mianserin
15
Nitazoxanideapproved, investigational, vet_approvedPhase 44555981-09-441684
Synonyms:
(2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat
2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide
2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide
2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
55981-09-4
AC-1302
AC1L26A1
AC1Q5NVY
AZT + Nitazoxanide
Adrovet
Alinia
Alinia (TN)
BRN 1225475
C12H9N3O5S
CHEMBL1401
CID41684
CPD000466367
Colufase
Cryptaz
D02486
DB00507
Daxon
Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide
EINECS 259-931-8
FT-0082459
HMS2051L04
Heliton
I14-6011
LS-144176
MLS000759492
MLS001424074
MolPort-002-042-244
N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
 
N-(5-Nitrothiazol-2-yl)salicylamide acetate ester
NCGC00090774-01
NCI60_034935
NCIMech_000843
NITAZOXANIDE
NSC 697855
NSC697855
Nitaxozanid
Nitaxozanide
Nitazoxanid
Nitazoxanida
Nitazoxanida [INN-Spanish]
Nitazoxanide (USAN/INN)
Nitazoxanide [USAN:INN]
Nitazoxanidum
Nitazoxanidum [INN-Latin]
Nodik
Omniparax
Oprea1_263587
Phavic-1
S1627_Selleck
SAM001246708
SBB068315
SMR000466367
STK395664
Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)
Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester)
Taenitaz
Tizoxanide Glucuronide
Tizoxanide glucuronide
UNII-SOA12P041N
ZINC03956788
[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate
azt+ nitazoxanide
o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate
16
PancrelipaseapprovedPhase 4, Phase 3, Phase 297053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
17
Pregabalinapproved, illicit, investigationalPhase 4361148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
18
NorepinephrineapprovedPhase 4, Phase 369951-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
19
Triamcinoloneapproved, vet_approvedPhase 4, Phase 2, Phase 3, Phase 1510124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
20
MirtazapineapprovedPhase 49085650-52-8, 61337-67-54205
Synonyms:
(1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
(N-methyl-11C)mirtazapine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
6-Azamianserin
61337-67-5
82601-27-2
85650-52-8
AC-15480
AC1L1HND
AC1Q3ZYM
Avanza
Axit
Azamianserin
BRD-A64977602-001-01-9
C035133
C07570
CHEBI:6950
CHEMBL654
CID4205
CPD000466347
Celltech brand of mirtazapine
D00563
DB00370
EINECS 288-060-6
HMS2052H03
I01-1882
I06-0606
L001294
LS-127703
LS-185067
M0443_SIGMA
ME-2040
MLS000759460
MLS001076676
Mepirzapin
 
Mepirzapine
Mepirzepine
Mirtabene
Mirtaz
Mirtazapin
Mirtazapina
Mirtazapina [INN-Spanish]
Mirtazapine
Mirtazapine (JAN/USAN/INN)
Mirtazapine [USAN:BAN:INN]
Mirtazapine [USAN:INN:BAN]
Mirtazapine [Usan:Ban:Inn]
Mirtazapinum
Mirtazapinum [INN-Latin]
Mirtazepine
Mirtazipine
Mirtazon
MolPort-003-849-233
Mundogen brand of mirtazapine
NCGC00025346-02
Norset
ORG 3770
Org-3770
Organon brand of mirtazapine
PDSP1_001529
PDSP2_001513
Promyrtil
Remergil
Remergon
Remeron
Remeron (TN)
Remeron SolTab
Remeron Soltab
Rexer
SAM001246659
SMR000466347
STK711107
UNII-A051Q2099Q
Zispin
mirtazapine
21
CitalopramapprovedPhase 451259729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
22
BenzocaineapprovedPhase 4, Phase 3, Phase 220161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
23
Risperidoneapproved, investigationalPhase 4492106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
24
DopamineapprovedPhase 4, Phase 3, Phase 2, Phase 1383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
25
ZincapprovedPhase 4, Phase 322967440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
26
LoxapineapprovedPhase 4, Phase 1311977-10-23964
Synonyms:
1977-10-2
2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine
2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine
2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine
27833-64-3 (succinate)
54810-23-0 (mono-hydrochloride)
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine
AC1L1H3Z
AC1Q3ZWR
BPBio1_000226
BRD-K39915878-036-04-6
BRD-K39915878-036-05-3
BRN 0626753
BSPBio_000204
BSPBio_003479
C07104
C18H18ClN3O
CHEBI:50841
CHEMBL831
CID3964
CL 62362
CL-62362
CL-71,563
Cloxazepine
D02340
DB00408
Dibenzacepin
Dibenzoazepine
DivK1c_006919
EINECS 217-835-3
HF 3170
HF3170
HSDB 3111
Hydrofluoride 3170
KBio1_001863
KBio2_000835
KBio2_003403
KBio2_005971
KBio3_002983
KBioSS_000835
L001085
 
LS-61562
LW 3170
Lopac0_000720
Lossapina
Lossapina [DCIT]
Loxapin
Loxapina
Loxapina [INN-Spanish]
Loxapine
Loxapine (USAN/INN)
Loxapine [USAN:BAN:INN]
Loxapine [USAN:INN:BAN]
Loxapinsuccinate
Loxapinum
Loxapinum [INN-Latin]
Loxepine
Loxitane IM
MolPort-002-885-838
NCGC00021145-01
NCGC00021145-07
NCGC00022279-03
NCGC00022279-04
NCGC00022279-05
Oxilapine
PDSP1_001058
PDSP2_001042
Prestwick0_000132
Prestwick1_000132
Prestwick2_000132
Prestwick3_000132
QTL1_000050
S 805
S-805
SPBio_001814
SPBio_002143
SUM 3170
SUM-3170
SpecPlus_000823
Spectrum2_001737
Spectrum3_001830
Spectrum5_001857
Spectrum_000355
UNII-LER583670J
ZINC19796158
loxapine
oxilapine
27
FlunarizineapprovedPhase 4552468-60-7941361
Synonyms:
(E)-1-(Bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)piperazine
(E)-1-[Bis-(p-fluorophenyl)methyl]-4-cinnamylpiperazine
1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine
1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-en-1-yl)piperazine
1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine
1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine
30484-77-6 (di-hydrochloride)
40218-96-0
52468-60-7
5343-57-7
AC-1283
AC1LIZWP
AC1Q4NMD
AR-1B9446
Apo-flunarizine capsules
BCBcMAP01_000120
BPBio1_000336
BRD-K12184470-300-01-8
BRD-K29582677-001-02-7
BRD-K29582677-300-05-6
BSPBio_000304
BSPBio_001341
BSPBio_003096
Bio-0741
C26H26F2N2
CHEBI:138764
CHEMBL30008
CID941361
D07971
DB04841
EINECS 254-842-0
EINECS 257-937-5
Flufenal
Flunarizin
Flunarizina
 
Flunarizina [INN-Spanish]
Flunarizina [inn-spanish]
Flunarizine (INN)
Flunarizine Hydrochloride
Flunarizine [INN:BAN]
Flunarizine dihydrochloride
Flunarizinum
Flunarizinum [INN-Latin]
Flunarizinum [inn-latin]
Fluvert
HMS1361D03
HMS1791D03
HMS1989D03
HMS2089H21
IDI1_000043
IDI1_033811
Issium
KST-1B4966
LS-110464
Lopac0_000527
MolPort-000-732-712
NCGC00018102-09
NCGC00024308-04
NCGC00024308-05
NCGC00024308-06
NCGC00024308-07
Novo-Flunarizine
Prestwick2_000312
Prestwick3_000312
R-14950
Sibelium
Sibelium (TN)
Spectrum5_001570
Vertix
Zinasen
flunarizine
28
Mycophenolate mofetilapproved, investigationalPhase 4, Phase 2952128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
29
Penicillin Vapproved, vet_approvedPhase 41787-08-16869
Synonyms:
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1098-87-9 (mono-hydrochloride salt)
132-98-9
132-98-9 (mono-potassium salt)
147-48-8 (mono-hydrochloride salt)
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carbonyl
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid
3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN)
4-27-00-05884 (Beilstein Handbook Reference)
6-Phenoxyacetamidopenicillanic acid
6-phenoxyacetamidopenicillanic acid
87-08-1
AB00514745
AC1L1NHG
AC1Q5QX3
AR-1H6492
Acipen V
Apocillin
Apopen
BRD-K43966364-237-02-2
BRN 0096259
BSPBio_002185
Beepen-VK
Beromycin
Beromycin, Penicillin
Berromycin, Penicillin
Betapen-VK
Bio-0630
C08126
C16H18N2O5S
CCRIS 752
CHEBI:27446
CHEBI:53706
CHEMBL615
CID6869
Calcipen
Compocillin V
Crystapen V
D05411
DB00417
DB08415
Distaquaine V
DivK1c_000779
EINECS 201-722-0
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [DCIT]
Fenossimetilpenicillina [Dcit]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
HSDB 6314
IDI1_000779
KBio1_000779
KBio2_001487
KBio2_004055
KBio2_006623
KBio3_001685
KBioGR_000944
KBioSS_001487
 
LS-1861
MLS001304105
Meropenin
MolPort-002-515-462
NCGC00159342-02
NINDS_000779
Oracillin
Oratren
Ospen
P-Mega-Tablinen
PNV
PV
PVA
Pen-Oral
Pen-V
Pen-vee
Penapar-Vk
Penicillin Phenoxymethyl
Penicillin V
Penicillin V (USP)
Penicillin V Potassium
Penicillin V [USAN]
Penicillin phenoxymethyl
Penicillin, Phenoxymethyl
Penicillin-Vk
Phenocillin
Phenomycilline
Phenopenicillin
Phenoximethylpenicillinum
Phenoxomethylpenicillin
Phenoxymethyl Penicillin
Phenoxymethyl penicillin
Phenoxymethylenepenicillinic Acid
Phenoxymethylenepenicillinic acid
Phenoxymethylpenicillin
Phenoxymethylpenicillin (INN)
Phenoxymethylpenicillin Potassium
Phenoxymethylpenicilline
Phenoxymethylpenicilline [INN-French]
Phenoxymethylpenicillinic Acid
Phenoxymethylpenicillinic Acid Potassium Salt
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinum
Phenoxymethylpenicillinum [INN-Latin]
Phénoxyméthylpénicilline
Robicillin
Rocilin
SMR000539431
SPBio_000389
Spectrum2_000495
Spectrum3_000543
Spectrum4_000472
Spectrum5_001409
Spectrum_001007
Stabicillin
UNII-Z61I075U2W
V-Cil
V-Cillin
V-Cillin (TN)
V-Cillin K
V-Cylina
V-Cyline
V-Tablopen
Vebecillin
Vegacillin
acipen-v
penicillin v
phenoxomethylpenicillanyl
phenoxomethylpenicillin
phenoxymethylpenicillanyl
phenoxymethylpenicillinic acid
30
PenicillamineapprovedPhase 4752-67-55852, 4727
Synonyms:
(-)-Penicillamine
(2S)-2-Amino-3-methyl-3-sulfanylbutanoic acid
(2S)-2-amino-3-methyl-3-sulfanyl-butanoic acid
(D)-PENICILLAMINE
(S)-2-amino-3-mercapto-3-methylbutanoic acid
(S)-3,3-Dimethylcysteine
(S)-3,3-dimethylcysteine
(S)-Penicillamin
(S)-Penicillamine
(−)-penicillamine
16414-54-3
2-Amino-3-mercapto-3-methylbutanoic acid
3,3-Dimethyl-D-cysteine
3-Mercapto-D-valine
3-Mercaptovaline
3-mercapto-D-valine
3-sulfanyl-D-valine
52-67-5
76400_FLUKA
AC1L1L9Z
AC1Q1NP9
AC1Q1NPA
Artamine
BSPBio_002181
Bio-0578
C07418
CCRIS 2904
CHEBI:7959
CHEMBL1430
CID5852
CPD-7702
Copper penicillaminate
Cuprenil
Cuprimine
Cuprimine (TN)
Cupripen
D 3 Mercaptovaline
D Penicillamine
D-(-)-2-Amino-3-mercapto-3-methylbutanoic acid
D-(-)-Penicillamine
D-(−)-penicillamine
D-3-Mercaptovaline
D-Mercaptovaline
D-Penamine
D-Penicilamine
D-Penicillamine
D-Penicyllamine
D-beta,beta-Dimethylcysteine
D-beta-Mercaptovaline
D-penicillamine
D-β,β-dimethylcysteine
D00496
D010396
DB00859
Depamine
Depen
Depen (TN)
Dimethylcysteine
Distamine (*Hydrochloride*)
DivK1c_000314
EINECS 200-148-8
 
Emtexate
HSDB 3378
IDI1_000314
InChI=1/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8
KBio1_000314
KBio2_000763
KBio2_003331
KBio2_005899
KBio3_001681
KBioGR_000920
KBioSS_000763
Kuprenil
L-Penicillamine
LS-161321
Mercaptovaline
Mercaptyl
Metalcaptase
Metalcaptase (*Hydrochloride*)
MolPort-001-792-382
NCGC00018283-01
NCGC00024359-04
NCGC00024359-05
NINDS_000314
NSC 81549
NSC81549
P-1280
P0147
P4875_SIGMA
PA
Pendramine
Penicilamina
Penicilamina [INN-Spanish]
Penicillamin
Penicillamina
Penicillamina [DCIT]
Penicillaminate, Copper
Penicillamine (JAN/USP/INN)
Penicillamine [USAN:INN:BAN:JAN]
Penicillaminum
Penicillaminum [INN-Latin]
Penicilllamine
Perdolat
Reduced D-penicillamine
Reduced penicillamine
S1853_Selleck
SMP1_000042
SPBio_001217
Spectrum2_001029
Spectrum3_000541
Spectrum4_000470
Spectrum5_001196
Spectrum_000283
Sufirtan
Sufortan
TBB068824
Trolovol
UNII-GNN1DV99GX
alpha-Amino-beta-methyl-beta-mercaptobutyric acid
beta,beta Dimethylcysteine
beta,beta-Dimethylcysteine
beta-Thiovaline
d,3-Mercaptovaline
penicillamine
31
TicagrelorapprovedPhase 4, Phase 3316274693-27-59871419
Synonyms:
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
AZD 6140
 
AZD-6140
AZD6140
Brilinta
32
Mycophenolic acidapprovedPhase 4, Phase 295224280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
33
Sirolimusapproved, investigationalPhase 4, Phase 3, Phase 2194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
34
Insulin DetemirapprovedPhase 4195169148-63-45311023
Synonyms:
Detemir
 
Insulin detemir recombinant
Insulin,detemir,human
35
EverolimusapprovedPhase 4, Phase 3, Phase 21940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
36
EnalaprilatapprovedPhase 412476420-72-96917719
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
76420-72-9
AC1NUWEA
AC1OCEK7
BIDD:GT0752
C11720
C18H24N2O5.2H2O
CHEBI:116759
CHEBI:42302
CHEBI:4786
CHEBI:59877
CHEMBL1200697
CHEMBL577
CID5462501
CID6917719
CPD000466359
D03769
EAL
ENALAPRILAT INHIBITOR
Enalapril acid
Enalapril diacid
Enalaprilat
Enalaprilat (USP)
 
Enalaprilat anhydrous
Enalaprilate
Enalaprilatum
Enalaprilic acid
Enalprilate hydrate
HMS2051H16
HMS2089P04
LS-118903
LS-187219
MK-422
MLS000759476
MLS001424138
MolPort-005-943-792
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline--water (1/2)
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline—water (1/2)
NCGC00164593-01
S1657_Selleck
SAM001246684
SBB065733
SMR000466359
Vasotec I.V.
enalaprilat dihydrate
enalaprilat hydrate
enalprilat hydrate
enalprilate hydrate
37PiracetamapprovedPhase 41757491-74-9
38
Enalaprilapproved, vet_approvedPhase 412475847-73-35362032, 40466924
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
75847-73-3
AC1NTUS5
Analapril
BIDD:GT0751
BPBio1_000340
BSPBio_000308
BSPBio_003035
Bonuten
C06977
CAS-76095-16-4
CHEBI:116847
CHEBI:4784
CHEMBL578
CID5388962
D07892
DivK1c_000408
Enalapril
Enalapril (INN)
Enalapril (TN)
Enalapril Bp
Enalapril Maleate
Enalapril Richet
Enalaprila
Enalaprila [INN-Spanish]
Enalaprilat
Enalaprilum
 
Enalaprilum [INN-Latin]
Gadopril
HMS2090E08
IDI1_000408
KBio1_000408
KBio2_001787
KBio2_004355
KBio2_006923
KBio3_002535
KBioGR_000355
KBioSS_001787
Kinfil
LS-190651
MolPort-002-885-877
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline
N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline
NCGC00016932-01
NCGC00021569-04
NCGC00021569-05
NCGC00021569-06
NINDS_000408
Prestwick3_000314
SPBio_001349
Spectrum2_001455
Spectrum3_001478
Spectrum4_000008
Spectrum5_001107
Spectrum_001307
Vaseretic
Vasotec
Vasotec IV
enalapril
39
RivaroxabanapprovedPhase 4259366789-02-8
Synonyms:
 
Xarelto
bay 59-7939
40
WarfarinapprovedPhase 447081-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
41
ApixabanapprovedPhase 4, Phase 3154503612-47-310182969
Synonyms:
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd
2p16
503612-47-3
AKOS005146204
Apixaban
Apixaban (JAN/USAN/INN)
BMS 562247-01
BMS-562247
BMS-562247-01
BMS-562247-01, Apixaban
 
CHEBI:49620
CHEMBL231779
CID10182969
D03213
DB07828
GG2
S1593_Selleck
UNII-3Z9Y7UWC1J
apixabanum
apixabán
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
42
SertralineapprovedPhase 429979617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-sertraline
sertraline
sertraline (Zoloft)
43
LorazepamapprovedPhase 4, Phase 1124846-49-13958
Synonyms:
(+-)-7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
(+/-)-Lorazepam
(±)-Lorazepam
5-25-02-00248 (Beilstein Handbook Reference)
7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1H-1,4-benzodiazepin-2(3H)-one
7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
846-49-1
AC1L1H3H
AHP Brand of Lorazepam
Almazine
Alzapam
Anxiedin
Anxira
Anzepam
Aplacasse
Aplacassee
Apo Lorazepam
Apo-Lorazepam
ApoLorazepam
Apotex Brand of Lorazepam
Aripax
Ativan
Ativan (TN)
Azurogen
BRN 0759084
Baxter Brand of Lorazepam
Bonatranquan
Bonton
CHEBI:116959
CHEMBL580
CID3958
CPD000058410
D00365
D008140
DB00186
DEA No. 2885
Delormetazepam
Demethyllormetazepam
Desitin Brand of Lorazepam
DivK1c_000965
Dolorgiet Brand of Lorazepam
Donix
Duralozam
Durazolam
EINECS 212-687-6
Efasedan
Emotion
Emotival
Equitam
HMS2052H07
HMS503A11
IDI1_000965
Idalprem
KBio1_000965
Kalmalin
L-Lorazepam Acetate
L1764_SIGMA
LS-34141
Larpose
Laubeel
Llorens Brand of Lorazepam
Lomesta
Lopam
Lorabenz
Lorafen
Loram
Lorans
Lorapam
Lorat
Lorax
Loraz
Lorazene
Lorazep
Lorazepam (JP15/USP/INN)
Lorazepam AHP Brand
Lorazepam Apotex Brand
Lorazepam Baxter Brand
Lorazepam Desitin Brand
Lorazepam Dolorgiet Brand
Lorazepam Fabra
Lorazepam Genericon
Lorazepam Intensol
Lorazepam Lannacher
Lorazepam Llorens Brand
Lorazepam Medical
Lorazepam Medical Brand
Lorazepam Medix Brand
Lorazepam Novartis Brand
Lorazepam Novopharm Brand
Lorazepam Nu-Pharm Brand
Lorazepam Riemser Brand
Lorazepam Wyeth Brand
Lorazepam [USAN:INN:BAN:JAN]
Lorazepam ct-Arzneimittel Brand
 
Lorazepam neuraxpharm
Lorazepam neuraxpharm Brand
Lorazepam preservative free
Lorazepam ratiopharm
Lorazepam ratiopharm Brand
Lorazepam-Efeka
Lorazepam-neuraxpharm
Lorazepam-ratiopharm
Lorazepamum
Lorazepamum [INN-Latin]
Lorazepan Chobet
Lorazepan Richet
Lorazin
Lorazon
Lorenin
Loridem
Lorivan
Lormetazepam
Lorsedal
Lorsilan
Lorzem
Lozepam
Max Pax
Medical Brand of Lorazepam
Medical, Lorazepam
Medix Brand of Lorazepam
Merck dura Brand of Lorazepam
Merlit
Methyllorazepam
MolPort-002-051-769
N-Methyllorazepam
NCGC00159439-02
NINDS_000965
NSC 289758
NSC289758
Nervistop L
Nervistopl
Norlormetazepam
Novartis Brand of Lorazepam
Novhepar
Novo Lorazem
Novo-Lorazem
Novolorazem
Novopharm Brand of Lorazepam
Nu Loraz
Nu Pharm Brand of Lorazepam
Nu-Loraz
Nu-Pharm Brand of Lorazepam
NuLoraz
O-Chlorooxazepam
O-Chloroxazepam
Orfidal
Orfidal Wyeth
Pro Dorm
Pro dorm
Psicopax
Punktyl
Quait
Renaquil
Riemser Brand of Lorazepam
Rocosgen
SAM001246833
Securit
Sedatival
Sedazin
Sedicepan
Sedizepan
Serra Pamies Brand of Lorazepam
Sidenar
Silence
Sinestron
Somagerol
Stapam
Tavor
Temesta
Tolid
Tranqipam
Trapax
UNII-O26FZP769L
Upan
Vigiten
WLN: T67 GMV JN IHJ CG IQ KR BG
WY4036
Wy 4036
Wy-4036
Wyeth Brand of Lorazepam
Wyeth, Orfidal
Wypax
ct Arzneimittel Brand of Lorazepam
ct-Arzneimittel Brand of Lorazepam
lorazep von ct
lorazepam
lorazepam (Ativan)
nchembio747-comp26
neuraxpharm Brand of Lorazepam
o-Chlorooxazepam
o-Chloroxazepam
ratiopharm Brand of Lorazepam
44
Tacrolimusapproved, investigationalPhase 4, Phase 21102104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
45
HaloperidolapprovedPhase 4, Phase 114752-86-83559
Synonyms:
1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine
4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
5-21-02-00377 (Beilstein Handbook Reference)
52-86-8
AB00052008
AC-19691
AC1L1G7K
AC1Q77Z0
AKOS000280660
ALDO
Aldo
Aloperidin
Aloperidol
Aloperidolo
Aloperidolo [DCIT]
Aloperidolo [Italian]
Aloperidon
Apo-Haloperidol
BIDD:GT0128
BPBio1_000144
BPBio1_001231
BRD-K67783091-001-04-8
BRD-K67783091-001-05-5
BRN 0331267
BSPBio_000130
BSPBio_002096
Bio-0705
Biomol-NT_000035
Bioperidolo
Brotopon
C01814
C21H23ClFNO2
CAS-52-86-8
CCRIS 1630
CHEBI:5613
CHEMBL54
CID3559
D00136
D006220
DB00502
DivK1c_000654
Dozic
Dozix
EINECS 200-155-6
EU-0100583
Einalon S
Eukystol
Fortunan
Galoperidol
H 1512
H0912
H1512_SIGMA
HMS1568G12
HMS1920D03
HMS2089M15
HMS2091J09
HMS502A16
HSDB 3093
Haldol
Haldol Decanoate
Haldol La
Haldol Solutab
Halidol
Halojust
Halol
Halopal
Haloperido
Haloperidol (JP15/USP)
Haloperidol (JP15/USP/INN)
Haloperidol Decanoate
Haloperidol Intensol
Haloperidol Lactate
Haloperidol [USAN:INN:BAN:JAN]
Haloperidolum
Haloperidolum [INN-Latin]
Halopidol
Halopoidol
Halosten
I14-13404
I14-14165
IDI1_000654
 
KBio1_000654
KBio2_001341
KBio2_002390
KBio2_003909
KBio2_004958
KBio2_006477
KBio2_007526
KBio3_001316
KBio3_002869
KBioGR_000980
KBioGR_002390
KBioSS_001341
KBioSS_002395
Keselan
L000288
LS-48311
Lealgin Compositum
Lealgin compositum
Linton
Lopac-H-1512
Lopac0_000583
MLS000028450
MLS001146904
McN-JR-1625
Mixidol
MolPort-000-883-311
NCGC00015500-01
NCGC00015500-02
NCGC00015500-06
NCGC00015500-14
NCGC00016234-01
NCGC00023875-02
NCGC00023875-04
NCGC00023875-05
NCGC00023875-06
NCGC00023875-07
NCGC00023875-08
NCGC00023875-09
NINDS_000654
NSC 170973
NSC 615296
NSC170973
NSC615296
Novo-Peridol
Oprea1_509923
Pekuces
Peluces
Peridol
Pernox
Pms Haloperidol
Prestwick0_000115
Prestwick1_000115
Prestwick2_000115
Prestwick3_000115
Prestwick_250
Probes1_000255
Probes2_000296
QTL1_000042
R 1625
R-1625
S1920_Selleck
SMR000058303
SPBio_001236
SPBio_002069
SPECTRUM1500325
Serenace
Serenase
Serenelfi
Sernas
Sernel
Sigaperidol
Spectrum2_001268
Spectrum3_000448
Spectrum4_000570
Spectrum5_000788
Spectrum_000861
Tocris-0931
UNII-J6292F8L3D
Ulcolind
Uliolind
Vesalium
WLN: T6NTJ A3VR DF& DQ DR DG
cMAP_000037
gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
haloperidol
46
LinagliptinapprovedPhase 4139668270-12-010096344
Synonyms:
(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
(R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
668270-12-0
BI 1356
BI-1356
BI-1356-BS
CHEBI:49403
 
CHEBI:499873
CHEMBL237500
CID 10096344
CID10096344
Linagliptin
Ondero
Tradjenta
Trajenta
47
Paroxetineapproved, investigationalPhase 422861869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
48
LactuloseapprovedPhase 41014618-18-211333
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-O-b-D-Galactopyranosyl-D-Fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-D-Galactopyranosyl-D-Fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-Fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
 
Bifiteral
Cephulac
D-Lactulose
Lactulosa
Lactulose
Lactulosum
delta-Lactulose
lactulosa
lactulosum
49
Nitric OxideapprovedPhase 461710102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
50
Clopidogrelapproved, nutraceuticalPhase 4, Phase 3778120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8

Interventional clinical trials:

(show top 50)    (show all 627)
idNameStatusNCT IDPhase
1Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)Unknown statusNCT00680641Phase 4
2Targeting Synovitis in Early Rheumatoid ArthritisUnknown statusNCT00920478Phase 4
3Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL)Unknown statusNCT02170103Phase 4
4Safety and the Effects of Isolated Left Ventricular Pacing in Patients With BradyarrhythmiasUnknown statusNCT01717469Phase 4
5Study of Zinc for Wilson DiseaseCompletedNCT00004338Phase 4
6Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete AdherenceCompletedNCT00215579Phase 4
7OptiVol® Care PathwayCompletedNCT00847288Phase 4
8Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenCompletedNCT00346216Phase 4
9Dialysis Clinical Outcomes Revisited (DCOR) TrialCompletedNCT00324571Phase 4
10Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44CompletedNCT00948766Phase 4
11A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory ComplaintsCompletedNCT00276510Phase 4
12Combining Medications to Enhance Depression OutcomesCompletedNCT00590863Phase 4
13Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation TelangiectasiasCompletedNCT00725244Phase 4
14Irritable Bowel Syndrome Evaluation and Treatment in Primary CareCompletedNCT01641341Phase 4
15Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and InfantsCompletedNCT00702507Phase 4
16AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg UlcersCompletedNCT01084577Phase 4
17Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-PenicillamineRecruitingNCT02426905Phase 4
18Neurologic Signatures of Chronic Pain DisordersRecruitingNCT02747940Phase 4
19Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in ChildrenRecruitingNCT02712996Phase 4
20Immunologic Response to Secukinumab in Plaque PsoriasisRecruitingNCT02592018Phase 4
21International Study to Predict Optimised Treatment - in DepressionRecruitingNCT00693849Phase 4
22A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery DiseaseRecruitingNCT02100722Phase 4
23Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial AppendageRecruitingNCT01721447Phase 4
24Effect of DPP4 Inhibition on VasoconstrictionRecruitingNCT02639637Phase 4
25EVOLVE Short DAPT StudyRecruitingNCT02605447Phase 4
26Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia ARecruitingNCT01811875Phase 4
27A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)RecruitingNCT02451137Phase 4
28Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or PlaceboRecruitingNCT00351611Phase 4
29Renal Transplantation in the Elderly - nEverOld StudyRecruitingNCT01631058Phase 4
30Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)RecruitingNCT02021032Phase 4
31Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee ReplacementRecruitingNCT02810704Phase 4
32Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by StreptococciRecruitingNCT02712307Phase 4
33Seizure Prophylaxis in Aneurysm RepairRecruitingNCT01801072Phase 4
34A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the HeartRecruitingNCT02415400Phase 4
35Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)Active, not recruitingNCT01897532Phase 4
36CPET in CF Patients With One G551D Mutation Taking VX770Active, not recruitingNCT01937325Phase 4
37Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for ConstipationNot yet recruitingNCT03148002Phase 4
38Effective Management of Emotional Response to Generate Well-Being Post-HF ExacerbationNot yet recruitingNCT03043261Phase 4
39ACTICOAT™ for the Treatment of Burns and Chronic WoundsNot yet recruitingNCT02852148Phase 4
40Inhaled Loxapine vs IM Haloperidol + Lorazepam for AgitationNot yet recruitingNCT03110900Phase 4
41Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With RisperdalTerminatedNCT00314613Phase 4
42NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated CardiomyopathyTerminatedNCT00293137Phase 4
43Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL ImplantationWithdrawnNCT00366613Phase 4
44Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study)Unknown statusNCT00920127Phase 2, Phase 3
4518F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in OncologyUnknown statusNCT00207298Phase 3
46Glaser Obesity StudyUnknown statusNCT00209482Phase 2, Phase 3
47Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilUnknown statusNCT00389870Phase 3
48Myocardial Protection With Perhexiline in Left Ventricular HypertrophyUnknown statusNCT00989508Phase 2, Phase 3
49Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.CompletedNCT00212355Phase 3
50Study of Tetrathiomolybdate in Patients With Wilson DiseaseCompletedNCT00004339Phase 3

Search NIH Clinical Center for Wilson Disease

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: hepatolenticular degeneration

Genetic Tests for Wilson Disease

About this section

Genetic tests related to Wilson Disease:

id Genetic test Affiliating Genes
1 Wilson Disease27 24 ATP7B

Anatomical Context for Wilson Disease

About this section

MalaCards organs/tissues related to Wilson Disease:

36
Liver, Brain, Eye, Testes, Kidney, Skin, Bone

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Wilson Disease:
id TissueAnatomical CompartmentCell Relevance
1 LiverLiver LobuleHepatocytes Potential therapeutic candidate, affected by disease

Publications for Wilson Disease

About this section

Articles related to Wilson Disease:

(show top 50)    (show all 664)
idTitleAuthorsYear
1
Wilson disease: symptomatic liver therapy. (28433104)
2017
2
The genetics of Wilson disease. (28433102)
2017
3
Wilson disease: brain pathology. (28433113)
2017
4
A 6-year-old boy with Wilson disease-A diagnostic dilemma. (28435998)
2017
5
Animal models of Wilson disease. (28433110)
2017
6
Other organ involvement and clinical aspects of Wilson disease. (28433099)
2017
7
Pontomesencephalic Atrophy and Postural Instability in Wilson Disease. (28495941)
2017
8
Patient support groups in the management of Wilson disease. (28433107)
2017
9
Wilson disease - currently used anticopper therapy. (28433101)
2017
10
Epidemiology and introduction to the clinical presentation of Wilson disease. (28433111)
2017
11
Wilson disease in children. (28433098)
2017
12
Novel perspectives on Wilson disease treatment. (28433106)
2017
13
Symptomatic treatment of neurologic symptoms in Wilson disease. (28433105)
2017
14
Diagnosis of Wilson disease. (28433100)
2017
15
Zinc monotherapy for young children with presymptomatic Wilson disease: a multicenter study in Japan. (28452067)
2017
16
Wilson disease - liver pathology. (28433112)
2017
17
Liver transplantation for Wilson disease. (28433103)
2017
18
Pathogenesis of Wilson disease. (28433109)
2017
19
Genetic and environmental modifiers of Wilson disease. (28433108)
2017
20
Lipid and copper metabolism in humans with wilson disease: Enigmatic relationship. (27859441)
2017
21
Hepatic features of Wilson disease. (28433114)
2017
22
Advantages of Anterior Segment Optical Coherence Tomography Evaluation of the Kayser-Fleischer Ring in Wilson Disease. (28060027)
2017
23
Neurological features and management of Wilson disease in children: an evaluation of 12 cases. (27103860)
2016
24
Copper induces hepatocyte injury due to the endoplasmic reticulum stress in cultured cells and patients with Wilson disease. (27502587)
2016
25
Rare diseases: Bacterial peptide reverses Wilson disease. (27469231)
2016
26
Diffusion tensor imaging of the extracorticospinal network in the brains of patients with Wilson disease. (26944166)
2016
27
Wilson Disease. (27495207)
2016
28
The Clinical Utility of a Low Serum Ceruloplasmin Measurement in the Diagnosis of Wilson Disease. (26904791)
2016
29
The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders. (26747866)
2016
30
Disease-causing point-mutations in metal-binding domains of Wilson disease protein decrease stability and increase structural dynamics. (27744583)
2016
31
A microbial peptide to rescue severe and fulminant Wilson disease? (27743981)
2016
32
Wilson Disease: epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model. (27611852)
2016
33
Methanobactin reverses acute liver failure in a rat model of Wilson disease. (27322060)
2016
34
ATP7B Gene Mutations in Croatian Patients with Wilson Disease. (26799313)
2016
35
Rapid and reliable diagnosis of Wilson disease using X-ray fluorescence. (27499926)
2016
36
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database. (27350316)
2016
37
Spectrum of ATP7B mutations and genotype-phenotype correlation in a large-scale Chinese patients with Wilson Disease. (27982432)
2016
38
MR imaging features of liver involvement by Wilson disease in adult patients. (27105862)
2016
39
Four-year follow-up of a Wilson disease pedigree complicated with epilepsy and hypopituitarism: Case report with a literature review. (27930511)
2016
40
MR imaging features of focal liver lesions in Wilson disease. (27116011)
2016
41
Management for acute liver failure of Wilson disease: Indication for liver transplantation. (27061913)
2016
42
Phenotypic convergence of Menkes and Wilson disease. (27878136)
2016
43
The Challenges of Diagnosing and Following Wilson Disease in the Presence of Proteinuria. (27437191)
2016
44
Liver: Novel therapeutic strategy for Wilson disease. (27407047)
2016
45
Mutational analysis of ATP7B in Chinese Wilson disease patients. (27398169)
2016
46
Aberrance of Serum Zinc and Free Copper Level in Wilson Disease. (26690865)
2016
47
Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants. (26660341)
2016
48
To the Editor: Wilson disease. (27281247)
2016
49
Pyoderma Gangrenosum-A New Manifestation of Wilson Disease? (27194899)
2016
50
Near-Infrared Upconversion Chemodosimeter for In Vivo Detection of Cu(2+) in Wilson Disease. (27185083)
2016

Variations for Wilson Disease

About this section

UniProtKB/Swiss-Prot genetic disease variations for Wilson Disease:

70 (show all 195)
id Symbol AA change Variation ID SNP ID
1ATP7Bp.Gly85ValVAR_000703rs786204643
2ATP7Bp.Leu492SerVAR_000710
3ATP7Bp.Gly626AlaVAR_000712rs587783299
4ATP7Bp.Asp642HisVAR_000713rs72552285
5ATP7Bp.Met645ArgVAR_000714rs121907998
6ATP7Bp.Gly691ArgVAR_000716rs121908001
7ATP7Bp.Leu708ProVAR_000717rs121908000
8ATP7Bp.Gly710ArgVAR_000718
9ATP7Bp.Gly710SerVAR_000719rs137853285
10ATP7Bp.Gly711GluVAR_000720
11ATP7Bp.Tyr713CysVAR_000721rs756883878
12ATP7Bp.Ile747PheVAR_000723
13ATP7Bp.Asp765AsnVAR_000724rs28942075
14ATP7Bp.Met769ValVAR_000725rs193922103
15ATP7Bp.Arg778GlyVAR_000727rs137853284
16ATP7Bp.Arg778LeuVAR_000728rs28942074
17ATP7Bp.Arg778GlnVAR_000729rs28942074
18ATP7Bp.Arg778TrpVAR_000730rs137853284
19ATP7Bp.Pro840LeuVAR_000733rs768671894
20ATP7Bp.Ile857ThrVAR_000734
21ATP7Bp.Gly869ArgVAR_000736rs191312027
22ATP7Bp.Ala874ValVAR_000737rs121907994
23ATP7Bp.Asp918AsnVAR_000738rs540935874
24ATP7Bp.Arg919GlyVAR_000739rs121907993
25ATP7Bp.Arg919TrpVAR_000740rs121907993
26ATP7Bp.Ser921AsnVAR_000741
27ATP7Bp.Thr935MetVAR_000743rs750019452
28ATP7Bp.Gly943AspVAR_000744rs779323689
29ATP7Bp.Gly943SerVAR_000745rs28942076
30ATP7Bp.Arg969GlnVAR_000747rs121907996
31ATP7Bp.Thr977MetVAR_000748rs72552255
32ATP7Bp.Pro992LeuVAR_000749rs201038679
33ATP7Bp.Ala1003ThrVAR_000751rs201497300
34ATP7Bp.Ala1018ValVAR_000752rs371840514
35ATP7Bp.Gly1035ValVAR_000753
36ATP7Bp.Leu1043ProVAR_000755
37ATP7Bp.Glu1064AlaVAR_000756rs374094065
38ATP7Bp.Glu1064LysVAR_000757rs376910645
39ATP7Bp.His1069GlnVAR_000758rs76151636
40ATP7Bp.Leu1083PheVAR_000759
41ATP7Bp.Gly1089GluVAR_000760
42ATP7Bp.Gly1089ValVAR_000761
43ATP7Bp.Gly1101ArgVAR_000762rs786204483
44ATP7Bp.Ile1102ThrVAR_000763rs560952220
45ATP7Bp.Gln1142HisVAR_000766rs778749563
46ATP7Bp.Val1146MetVAR_000767
47ATP7Bp.Ile1148ThrVAR_000768rs60431989
48ATP7Bp.Trp1153CysVAR_000769
49ATP7Bp.Met1169ValVAR_000770rs749085322
50ATP7Bp.Ala1183GlyVAR_000771rs587783315
51ATP7Bp.Gly1186CysVAR_000773
52ATP7Bp.Gly1213ValVAR_000775
53ATP7Bp.Val1216MetVAR_000776rs776280797
54ATP7Bp.Thr1220MetVAR_000778rs193922107
55ATP7Bp.Asp1222TyrVAR_000779
56ATP7Bp.Gly1266ValVAR_000781
57ATP7Bp.Asp1267AlaVAR_000782
58ATP7Bp.Asn1270SerVAR_000783rs121907990
59ATP7Bp.Pro1273LeuVAR_000784rs758355520
60ATP7Bp.Ser1310ArgVAR_000787rs749380700
61ATP7Bp.Arg1322ProVAR_000788
62ATP7Bp.Gly1341AspVAR_000789rs779494870
63ATP7Bp.Trp1353ArgVAR_000790
64ATP7Bp.Ala1358SerVAR_000791
65ATP7Bp.Arg616GlnVAR_009004rs752850609
66ATP7Bp.Gly711ArgVAR_009006
67ATP7Bp.Gly711TrpVAR_009007
68ATP7Bp.Ser744ProVAR_009008
69ATP7Bp.Met769ArgVAR_009009rs772595172
70ATP7Bp.Leu795ArgVAR_009010
71ATP7Bp.Gly869ValVAR_009011
72ATP7Bp.Cys985TyrVAR_009012
73ATP7Bp.Ala1003ValVAR_009013rs775055397
74ATP7Bp.Thr1033AlaVAR_009014
75ATP7Bp.Arg1041ProVAR_009015
76ATP7Bp.Pro1052LeuVAR_009016rs778543794
77ATP7Bp.Gly1061GluVAR_009017rs764131178
78ATP7Bp.Ala1063ValVAR_009018rs587783309
79ATP7Bp.Glu1068GlyVAR_009019
80ATP7Bp.Gln1095ProVAR_009020
81ATP7Bp.Cys1104PheVAR_009021
82ATP7Bp.Arg1151HisVAR_009022rs377297166
83ATP7Bp.Met1169ThrVAR_009023
84ATP7Bp.Glu1173LysVAR_009024rs756029120
85ATP7Bp.Val1239GlyVAR_009026rs374628199
86ATP7Bp.Val1262PheVAR_009027rs769484789
87ATP7Bp.Gly1266ArgVAR_009028rs121907992
88ATP7Bp.Leu1327ValVAR_009030
89ATP7Bp.Ser1363PheVAR_009031rs776848753
90ATP7Bp.Gly710AlaVAR_010010
91ATP7Bp.Tyr741CysVAR_010011rs770533110
92ATP7Bp.Gly891ValVAR_010012
93ATP7Bp.Ile967PheVAR_010013rs60003608
94ATP7Bp.Thr1031IleVAR_010014
95ATP7Bp.Arg1038LysVAR_010015rs59959366
96ATP7Bp.Val1106AspVAR_010017rs775541743
97ATP7Bp.Trp1153ArgVAR_010018
98ATP7Bp.Gly1176ArgVAR_010019rs137853279
99ATP7Bp.Asp1222ValVAR_010020
100ATP7Bp.Gly1355SerVAR_010021
101ATP7Bp.Asn41SerVAR_023011rs201738967
102ATP7Bp.Arg616TrpVAR_023012rs374172791
103ATP7Bp.Pro690LeuVAR_023014
104ATP7Bp.Ser693CysVAR_023015
105ATP7Bp.Ser721ProVAR_023016rs765667658
106ATP7Bp.Pro760LeuVAR_023018rs766907687
107ATP7Bp.Asp765GlyVAR_023019
108ATP7Bp.Pro768HisVAR_023020
109ATP7Bp.Met769IleVAR_023021
110ATP7Bp.Val890MetVAR_023023rs786204718
111ATP7Bp.Gln898ArgVAR_023024
112ATP7Bp.Asp918GluVAR_023025
113ATP7Bp.Val949GlyVAR_023026
114ATP7Bp.Ser975TyrVAR_023027rs778163447
115ATP7Bp.Thr1033SerVAR_023028
116ATP7Bp.Phe1094LeuVAR_023029
117ATP7Bp.Pro1098ArgVAR_023030
118ATP7Bp.Gly1099SerVAR_023031rs761632029
119ATP7Bp.Gly1111AspVAR_023032rs182659444
120ATP7Bp.Ala1168SerVAR_023034rs777879359
121ATP7Bp.Thr1232ProVAR_023035rs568009639
122ATP7Bp.Lys1248AsnVAR_023037
123ATP7Bp.Leu1255IleVAR_023038
124ATP7Bp.Asp1271AsnVAR_023039
125ATP7Bp.Asp1279GlyVAR_023040rs778914828
126ATP7Bp.Leu1305ProVAR_023041rs377144951
127ATP7Bp.Ile1336ThrVAR_023042
128ATP7Bp.Gly1355CysVAR_023043
129ATP7Bp.Leu1373ProVAR_023044
130ATP7Bp.Leu1373ArgVAR_023045rs780811477
131ATP7Bp.Ala486SerVAR_044454
132ATP7Bp.Tyr532HisVAR_044455
133ATP7Bp.Gly591AspVAR_044456rs797045402
134ATP7Bp.Ala604ProVAR_044457
135ATP7Bp.Ser653TyrVAR_044459
136ATP7Bp.Cys703TyrVAR_044460rs767218895
137ATP7Bp.Gly710ValVAR_044461
138ATP7Bp.Ala756GlyVAR_044462
139ATP7Bp.Thr766MetVAR_044463rs121907997
140ATP7Bp.Thr766ArgVAR_044464rs121907997
141ATP7Bp.Leu776ProVAR_044465
142ATP7Bp.Ala861ThrVAR_044466
143ATP7Bp.Gly875ValVAR_044467
144ATP7Bp.Gly943CysVAR_044468
145ATP7Bp.Gly988ArgVAR_044469rs199623434
146ATP7Bp.Thr991MetVAR_044470rs41292782
147ATP7Bp.Pro992HisVAR_044471
148ATP7Bp.Met996ThrVAR_044472rs770782111
149ATP7Bp.Gly1000ArgVAR_044473rs751078884
150ATP7Bp.Thr1029IleVAR_044474
151ATP7Bp.Ala1065ProVAR_044475
152ATP7Bp.Cys1104TyrVAR_044476rs764041557
153ATP7Bp.Gly1176GluVAR_044478
154ATP7Bp.Gly1221GluVAR_044480
155ATP7Bp.Asp1222AsnVAR_044481
156ATP7Bp.Val1252IleVAR_044482
157ATP7Bp.Gln1256ArgVAR_044483
158ATP7Bp.Asp1279TyrVAR_044484
159ATP7Bp.Gly1287SerVAR_044485rs762866453
160ATP7Bp.Asp1296AsnVAR_044486rs199821556
161ATP7Bp.Tyr1331SerVAR_044488
162ATP7Bp.Gly1341SerVAR_044489rs587783317
163ATP7Bp.Gly1341ValVAR_044490
164ATP7Bp.Pro1352SerVAR_044491
165ATP7Bp.Leu1368ProVAR_044492rs749171049
166ATP7Bp.Ser657ArgVAR_058926rs372436901
167ATP7Bp.Ala971ValVAR_058927rs770340441
168ATP7Bp.Thr974MetVAR_058928rs201061621
169ATP7Bp.Gln1004ProVAR_058929rs587783307
170ATP7Bp.Gly1149AlaVAR_058930
171ATP7Bp.Asp1164AsnVAR_058931rs867107727
172ATP7Bp.Glu1173GlyVAR_058932
173ATP7Bp.Arg1228ThrVAR_058933
174ATP7Bp.Ile1230ValVAR_058934rs200911496
175ATP7Bp.Asp1267ValVAR_058935
176ATP7Bp.Ala1328ThrVAR_058936
177ATP7Bp.Met1359IleVAR_058937rs759551693
178ATP7Bp.Leu549ProVAR_067335
179ATP7Bp.Gly998AspVAR_067336
180ATP7Bp.Asn1332AspVAR_067337
181ATP7Bp.Gly1341ArgVAR_067338
182ATP7Bp.Thr788IleVAR_075336rs541408630
183ATP7Bp.Val1036IleVAR_075337rs761147984
184ATP7Bp.Arg1151CysVAR_075338rs755554442
185ATP7Bp.Pro1245ThrVAR_075340
186ATP7Bp.Cys157PheVAR_076731rs551275663
187ATP7Bp.Arg827TrpVAR_076736rs539585071
188ATP7Bp.Lys1010ThrVAR_076744
189ATP7Bp.Ala1295AspVAR_076752
190ATP7Bp.Gly591SerVAR_076794
191ATP7Bp.Trp939CysVAR_076813
192ATP7Bp.Cys1104SerVAR_076816
193ATP7Bp.Pro539LeuVAR_076970rs572122562
194ATP7Bp.Trp779GlyVAR_076971rs751798708
195ATP7Bp.Arg816SerVAR_076972

Clinvar genetic disease variations for Wilson Disease:

5 (show all 128)
id Gene Variation Type Significance SNP ID Assembly Location
1ATP7BNM_ 000053.3(ATP7B): c.2128G> A (p.Gly710Ser)SNVPathogenicrs137853285GRCh38Chr 13, 51958538: 51958538
2ATP7BNM_ 000053.3(ATP7B): c.2332C> G (p.Arg778Gly)SNVLikely pathogenicrs137853284GRCh38Chr 13, 51958334: 51958334
3ATP7BNM_ 000053.3(ATP7B): c.2336G> A (p.Trp779Ter)SNVPathogenicrs137853283GRCh38Chr 13, 51958330: 51958330
4ATP7BNM_ 000053.3(ATP7B): c.122A> G (p.Asn41Ser)SNVPathogenic/ Likely pathogenicrs201738967GRCh37Chr 13, 52549234: 52549234
5ATP7BNM_ 000053.3(ATP7B): c.1969A> C (p.Ser657Arg)SNVPathogenicrs372436901GRCh37Chr 13, 52534436: 52534436
6ATP7BNM_ 000053.3(ATP7B): c.2605G> A (p.Gly869Arg)SNVPathogenicrs191312027GRCh37Chr 13, 52524268: 52524268
7ATP7BNM_ 000053.3(ATP7B): c.2865+1G> ASNVPathogenic/ Likely pathogenicrs587783306GRCh37Chr 13, 52523797: 52523797
8ATP7BNM_ 000053.3(ATP7B): c.3011A> C (p.Gln1004Pro)SNVPathogenicrs587783307GRCh37Chr 13, 52520469: 52520469
9ATP7BNM_ 000053.3(ATP7B): c.4021G> A (p.Gly1341Ser)SNVPathogenicrs587783317GRCh37Chr 13, 52511412: 52511412
10ATP7BNM_ 000053.3(ATP7B): c.4039G> A (p.Gly1347Ser)SNVLikely pathogenicrs587783318GRCh38Chr 13, 51935678: 51935678
11ATP7BNM_ 000053.3(ATP7B): c.2804C> T (p.Thr935Met)SNVLikely pathogenicrs750019452GRCh37Chr 13, 52523859: 52523859
12ATP7BNM_ 000053.3(ATP7B): c.3053C> T (p.Ala1018Val)SNVLikely pathogenicrs371840514GRCh37Chr 13, 52520427: 52520427
13ATP7BNM_ 000053.3(ATP7B): c.2731-2A> GSNVPathogenic/ Likely pathogenicrs367956522GRCh37Chr 13, 52523934: 52523934
14ATP7BNM_ 000053.3(ATP7B): c.2513delA (p.Lys838Serfs)deletionLikely pathogenicrs777362050GRCh37Chr 13, 52524470: 52524470
15ATP7BNM_ 000053.3(ATP7B): c.2575+1G> CSNVLikely pathogenicrs766149114GRCh37Chr 13, 52524407: 52524407
16ATP7BNM_ 000053.3(ATP7B): c.3008C> T (p.Ala1003Val)SNVLikely pathogenicrs775055397GRCh37Chr 13, 52520472: 52520472
17ATP7BNM_ 000053.3(ATP7B): c.3007G> A (p.Ala1003Thr)SNVLikely pathogenicrs201497300GRCh38Chr 13, 51946337: 51946337
18ATP7BNM_ 000053.3(ATP7B): c.3301G> A (p.Gly1101Arg)SNVLikely pathogenicrs786204483GRCh37Chr 13, 52516633: 52516633
19ATP7BNM_ 000053.3(ATP7B): c.2383C> T (p.Leu795Phe)SNVLikely pathogenicrs751710854GRCh37Chr 13, 52531716: 52531716
20ATP7BNM_ 000053.3(ATP7B): c.2975C> T (p.Pro992Leu)SNVPathogenicrs201038679GRCh37Chr 13, 52520505: 52520505
21ATP7BNM_ 000053.3(ATP7B): c.3451C> T (p.Arg1151Cys)SNVLikely pathogenicrs755554442GRCh38Chr 13, 51941186: 51941186
22ATP7BNM_ 000053.3(ATP7B): c.3646G> A (p.Val1216Met)SNVLikely pathogenicrs776280797GRCh37Chr 13, 52513240: 52513240
23ATP7BNM_ 000053.3(ATP7B): c.2009_ 2015delATATGCT (p.Tyr670Terfs)deletionLikely pathogenicrs779904655GRCh38Chr 13, 51960254: 51960260
24ATP7BNM_ 000053.3(ATP7B): c.2519C> T (p.Pro840Leu)SNVPathogenic/ Likely pathogenicrs768671894GRCh37Chr 13, 52524464: 52524464
25ATP7BNM_ 000053.3(ATP7B): c.2532delA (p.Val845Serfs)deletionPathogenicrs755709270GRCh37Chr 13, 52524451: 52524451
26ATP7BNM_ 000053.3(ATP7B): c.3263T> A (p.Leu1088Ter)SNVLikely pathogenicrs753250853GRCh38Chr 13, 51942535: 51942535
27ATP7BNM_ 000053.3(ATP7B): c.331C> T (p.Gln111Ter)SNVLikely pathogenicrs774221179GRCh38Chr 13, 51974889: 51974889
28ATP7BNM_ 000053.3(ATP7B): c.3556G> A (p.Gly1186Ser)SNVLikely pathogenicrs786204547GRCh37Chr 13, 52515217: 52515217
29ATP7BNM_ 000053.3(ATP7B): c.4088C> T (p.Ser1363Phe)SNVLikely pathogenicrs776848753GRCh38Chr 13, 51935629: 51935629
30ATP7BNM_ 000053.3(ATP7B): c.813C> A (p.Cys271Ter)SNVPathogenicrs572147914GRCh38Chr 13, 51974407: 51974407
31ATP7BNM_ 000053.3(ATP7B): c.778dupC (p.Gln260Profs)duplicationLikely pathogenicrs786204570GRCh37Chr 13, 52548578: 52548578
32ATP7BNM_ 000053.3(ATP7B): c.4051C> T (p.Gln1351Ter)SNVLikely pathogenicrs786204578GRCh38Chr 13, 51935666: 51935666
33ATP7BNM_ 000053.3(ATP7B): c.3244-2A> GSNVLikely pathogenicrs786204584GRCh37Chr 13, 52516692: 52516692
34ATP7BNM_ 000053.3(ATP7B): c.524_ 525delAA (p.Lys175Serfs)deletionLikely pathogenicrs558037268GRCh37Chr 13, 52548831: 52548832
35ATP7BNM_ 000053.3(ATP7B): c.3649_ 3654delGTTCTG (p.Val1217_ Leu1218del)deletionLikely pathogenicrs781266802GRCh37Chr 13, 52513232: 52513237
36ATP7BNM_ 000053.3(ATP7B): c.254G> T (p.Gly85Val)SNVLikely pathogenicrs786204643GRCh37Chr 13, 52549102: 52549102
37ATP7BNM_ 000053.3(ATP7B): c.3517G> A (p.Glu1173Lys)SNVLikely pathogenicrs756029120GRCh37Chr 13, 52515256: 52515256
38ATP7BNM_ 000053.3(ATP7B): c.3556+1G> ASNVLikely pathogenicrs184388696GRCh38Chr 13, 51941080: 51941080
39ATP7BNM_ 000053.3(ATP7B): c.3598C> T (p.Gln1200Ter)SNVLikely pathogenicrs786204658GRCh37Chr 13, 52513288: 52513288
40ATP7BNM_ 000053.3(ATP7B): c.2828G> A (p.Gly943Asp)SNVLikely pathogenicrs779323689GRCh37Chr 13, 52523835: 52523835
41ATP7BNM_ 000053.3(ATP7B): c.1782delT (p.Tyr594Terfs)deletionLikely pathogenicrs780327716GRCh38Chr 13, 51964959: 51964959
42ATP7BNM_ 000053.3(ATP7B): c.3552dupT (p.Asp1185Terfs)duplicationLikely pathogenicrs748924063GRCh38Chr 13, 51941085: 51941085
43ATP7BNM_ 000053.3(ATP7B): c.1924G> C (p.Asp642His)SNVLikely pathogenicrs72552285GRCh38Chr 13, 51961859: 51961859
44ATP7BNM_ 000053.3(ATP7B): c.1745_ 1746delTA (p.Ile582Argfs)deletionPathogenic/ Likely pathogenicrs753962912GRCh37Chr 13, 52539131: 52539132
45ATP7BNM_ 000053.3(ATP7B): c.1285+2T> ASNVLikely pathogenicrs759749626GRCh37Chr 13, 52548069: 52548069
46ATP7BNM_ 000053.3(ATP7B): c.2668G> A (p.Val890Met)SNVLikely pathogenicrs786204718GRCh37Chr 13, 52524205: 52524205
47ATP7BNM_ 000053.3(ATP7B): c.3818C> T (p.Pro1273Leu)SNVLikely pathogenicrs758355520GRCh38Chr 13, 51937561: 51937561
48ATP7BNM_ 000053.3(ATP7B): c.3895C> T (p.Leu1299Phe)SNVLikely pathogenicrs749472361GRCh37Chr 13, 52511620: 52511620
49ATP7BNM_ 000053.3(ATP7B): c.2035delC (p.His679Thrfs)deletionLikely pathogenicrs786204764GRCh38Chr 13, 51960234: 51960234
50ATP7BNM_ 000053.3(ATP7B): c.314C> A (p.Ser105Ter)SNVPathogenic/ Likely pathogenicrs753236073GRCh37Chr 13, 52549042: 52549042
51ATP7BNM_ 001243182.1(ATP7B): c.383delG (p.Gly128Glufs)deletionPathogenicrs797045083GRCh37Chr 13, 52548973: 52548973
52ATP7BNM_ 000053.3(ATP7B): c.1772G> A (p.Gly591Asp)SNVLikely pathogenicrs797045402GRCh37Chr 13, 52539105: 52539105
53ATP7BNM_ 000053.3(ATP7B): c.2165dupT (p.Arg723Glufs)duplicationPathogenicrs768729972GRCh38Chr 13, 51958501: 51958501
54ATP7BNM_ 000053.3(ATP7B): c.3505A> G (p.Met1169Val)SNVLikely pathogenicrs749085322GRCh37Chr 13, 52515268: 52515268
55ATP7BNM_ 000053.3(ATP7B): c.3809A> G (p.Asn1270Ser)SNV, CompoundHeterozygotePathogenicrs121907990GRCh37Chr 13, 52511706: 52511706
56ATP7BNM_ 000053.3(ATP7B): c.-441_ -427del15deletionPathogenicrs879255499GRCh38Chr 13, 52011764: 52011778
57ATP7BNM_ 000053.3(ATP7B): c.3664delG (p.Asp1222Thrfs)deletionPathogenic/ Likely pathogenicrs886042519GRCh37Chr 13, 52513222: 52513222
58ATP7BNM_ 000053.3(ATP7B): c.1609_ 1610insGGTCA (p.Ile537Argfs)insertionPathogenicrs886043238GRCh37Chr 13, 52542677: 52542678
59ATP7BNM_ 000053.3(ATP7B): c.3107dupT (p.Arg1038Glnfs)duplicationPathogenicrs886043423GRCh37Chr 13, 52518381: 52518381
60ATP7BNM_ 000053.3(ATP7B): c.3182G> A (p.Gly1061Glu)SNVPathogenicrs764131178GRCh37Chr 13, 52518306: 52518306
61ATP7BNM_ 000053.3(ATP7B): c.3121C> T (p.Arg1041Trp)SNVLikely pathogenicrs746485916GRCh37Chr 13, 52518367: 52518367
62ATP7BNM_ 000053.3(ATP7B): c.51+4A> TSNVLikely pathogenicrs369488210GRCh38Chr 13, 52011283: 52011283
63ATP7BNM_ 000053.3(ATP7B): c.2122-8T> GSNVPathogenic/ Likely pathogenicrs193922102GRCh38Chr 13, 51958552: 51958552
64ATP7BNM_ 000053.3(ATP7B): c.2930C> T (p.Thr977Met)SNVPathogenicrs72552255GRCh37Chr 13, 52520550: 52520550
65ATP7BNM_ 000053.3(ATP7B): c.2953T> C (p.Cys985Arg)SNVLikely pathogenicrs193922104GRCh37Chr 13, 52520527: 52520527
66ATP7BNM_ 000053.3(ATP7B): c.3659C> T (p.Thr1220Met)SNVPathogenic/ Likely pathogenicrs193922107GRCh37Chr 13, 52513227: 52513227
67ATP7BNM_ 000053.3(ATP7B): c.3700G> T (p.Val1234Phe)SNVLikely pathogenicrs193922108GRCh37Chr 13, 52511815: 52511815
68ATP7BNM_ 000053.3(ATP7B): c.3955C> T (p.Arg1319Ter)SNVPathogenic/ Likely pathogenicrs193922109GRCh37Chr 13, 52511478: 52511478
69ATP7BNM_ 000053.3(ATP7B): c.4058G> A (p.Trp1353Ter)SNVLikely pathogenicrs193922110GRCh37Chr 13, 52509795: 52509795
70ATP7BNM_ 000053.3(ATP7B): c.845delT (p.Leu282Profs)deletionPathogenicrs193922111GRCh37Chr 13, 52548511: 52548511
71ATP7BNM_ 000053.3(ATP7B): c.3191A> C (p.Glu1064Ala)SNVLikely pathogenicrs374094065GRCh37Chr 13, 52518297: 52518297
72ATP7BNM_ 000053.3(ATP7B): c.3942_ 3943delCA (p.Lys1315Glufs)deletionLikely pathogenicrs1057516227GRCh37Chr 13, 52511490: 52511491
73ATP7BNM_ 000053.3(ATP7B): c.3948delG (p.Thr1317Leufs)deletionLikely pathogenicrs1057516228GRCh38Chr 13, 51937349: 51937349
74ATP7BNM_ 000053.3(ATP7B): c.3426G> C (p.Gln1142His)SNVLikely pathogenicrs778749563GRCh37Chr 13, 52515347: 52515347
75ATP7BNM_ 000053.3(ATP7B): c.1708-1G> ASNVPathogenicrs137853280GRCh37Chr 13, 52539170: 52539170
76ATP7BNM_ 000053.3(ATP7B): c.1372G> T (p.Glu458Ter)SNVLikely pathogenicrs1057516305GRCh38Chr 13, 51970663: 51970663
77ATP7BNM_ 000053.3(ATP7B): c.2157C> A (p.Tyr719Ter)SNVLikely pathogenicrs1057516380GRCh38Chr 13, 51958509: 51958509
78ATP7BNM_ 000053.3(ATP7B): c.525dupA (p.Val176Serfs)duplicationPathogenicrs758115611GRCh37Chr 13, 52548831: 52548831
79ATP7BNM_ 000053.3(ATP7B): c.1470C> A (p.Cys490Ter)SNVLikely pathogenicrs778675259GRCh38Chr 13, 51970565: 51970565
80ATP7BNM_ 000053.3(ATP7B): c.1512dupT (p.Asn505Terfs)duplicationLikely pathogenicrs1057516418GRCh37Chr 13, 52544659: 52544659
81ATP7BNM_ 000053.3(ATP7B): c.2730+1G> ASNVLikely pathogenicrs1057516425GRCh37Chr 13, 52524142: 52524142
82ATP7BNM_ 000053.3(ATP7B): c.3529C> T (p.Gln1177Ter)SNVLikely pathogenicrs1057516479GRCh37Chr 13, 52515244: 52515244
83ATP7BNM_ 000053.3(ATP7B): c.103A> T (p.Lys35Ter)SNVLikely pathogenicrs1057516516GRCh37Chr 13, 52549253: 52549253
84ATP7BNM_ 000053.3(ATP7B): c.174dupC (p.Thr59Hisfs)duplicationLikely pathogenicrs1057516561GRCh37Chr 13, 52549182: 52549182
85ATP7BNM_ 000053.3(ATP7B): c.2810delT (p.Val937Glyfs)deletionPathogenic/ Likely pathogenicrs1057516643GRCh37Chr 13, 52523853: 52523853
86ATP7BNM_ 000053.3(ATP7B): c.2447+1delGdeletionLikely pathogenicrs1057516732GRCh37Chr 13, 52531651: 52531651
87ATP7BNM_ 000053.3(ATP7B): c.3800delA (p.Asp1267Valfs)deletionLikely pathogenicrs1057516740GRCh38Chr 13, 51937579: 51937579
88ATP7BNM_ 000053.3(ATP7B): c.3295G> A (p.Gly1099Ser)SNVLikely pathogenicrs761632029GRCh38Chr 13, 51942503: 51942503
89ATP7BNM_ 000053.3(ATP7B): c.2303C> T (p.Pro768Leu)SNVLikely pathogenicrs1057516844GRCh37Chr 13, 52532499: 52532499
90ATP7BNM_ 000053.3(ATP7B): c.1716delG (p.Met573Terfs)deletionLikely pathogenicrs1057516893GRCh37Chr 13, 52539161: 52539161
91ATP7BNM_ 000053.3(ATP7B): c.1820dupA (p.Phe608Valfs)duplicationLikely pathogenicrs1057516940GRCh37Chr 13, 52539057: 52539057
92ATP7BNM_ 000053.3(ATP7B): c.3104G> T (p.Gly1035Val)SNVLikely pathogenicrs753594031GRCh37Chr 13, 52518384: 52518384
93ATP7BNM_ 000053.3(ATP7B): c.1708-2A> GSNVLikely pathogenicrs1057517024GRCh38Chr 13, 51965035: 51965035
94ATP7BNM_ 000053.3(ATP7B): c.4114C> T (p.Gln1372Ter)SNVPathogenicrs755584106GRCh37Chr 13, 52509739: 52509739
95ATP7BNM_ 000053.3(ATP7B): c.3443T> C (p.Ile1148Thr)SNVPathogenic/ Likely pathogenicrs60431989GRCh37Chr 13, 52515330: 52515330
96ATP7BNM_ 000053.3(ATP7B): c.1337_ 1338insTT (p.Gln447Cysfs)insertionLikely pathogenicrs1057517141GRCh38Chr 13, 51970697: 51970698
97ATP7BNM_ 000053.3(ATP7B): c.4242delC (p.Arg1415Glyfs)deletionLikely pathogenicrs1057517191GRCh38Chr 13, 51934912: 51934912
98ATP7BNM_ 000053.3(ATP7B): c.3904-2A> GSNVPathogenicrs1057517233GRCh37Chr 13, 52511531: 52511531
99ATP7BNM_ 000053.3(ATP7B): c.4092_ 4093delGT (p.Ser1365Cysfs)deletionPathogenicrs771603301GRCh37Chr 13, 52509760: 52509761
100ATP7BNM_ 000053.3(ATP7B): c.2817G> T (p.Trp939Cys)SNVLikely pathogenicrs1057517310GRCh38Chr 13, 51949710: 51949710
101ATP7BNM_ 000053.3(ATP7B): c.3317T> A (p.Val1106Asp)SNVLikely pathogenicrs775541743GRCh37Chr 13, 52516617: 52516617
102ATP7BNM_ 000053.3(ATP7B): c.52-1G> TSNVLikely pathogenicrs1057517351GRCh38Chr 13, 51975169: 51975169
103ATP7BNM_ 000053.3(ATP7B): c.388_ 389dupGC (p.Ala131Glnfs)duplicationLikely pathogenicrs1057517384GRCh38Chr 13, 51974831: 51974832
104ATP7BNM_ 000053.3(ATP7B): c.1340_ 1343delAAAC (p.Gln447Leufs)deletionLikely pathogenicrs1057517444GRCh37Chr 13, 52544828: 52544831
105ATP7BATP7B, 7-BP DEL, NT2010deletionPathogenic
106ATP7BATP7B, 1-BP DEL, 2337CdeletionPathogenic
107ATP7BATP7B, 1-BP INS, NT2487insertionPathogenic
108ATP7BNM_ 000053.3(ATP7B): c.3207C> A (p.His1069Gln)SNVPathogenicrs76151636GRCh37Chr 13, 52518281: 52518281
109ATP7BNM_ 000053.3(ATP7B): c.3796G> A (p.Gly1266Arg)SNVPathogenicrs121907992GRCh37Chr 13, 52511719: 52511719
110ATP7BNM_ 000053.3(ATP7B): c.1708-1G> CSNVPathogenic/ Likely pathogenicrs137853280GRCh37Chr 13, 52539170: 52539170
111ATP7BNM_ 000053.3(ATP7B): c.2621C> T (p.Ala874Val)SNVPathogenicrs121907994GRCh37Chr 13, 52524252: 52524252
112ATP7BNM_ 000053.3(ATP7B): c.2333G> T (p.Arg778Leu)SNVPathogenicrs28942074GRCh37Chr 13, 52532469: 52532469
113ATP7BATP7B, 15-BP DEL, NT-441deletionPathogenic
114ATP7BATP7B, 3-BP DEL, 3892GTCdeletionPathogenic
115ATP7BNM_ 000053.3(ATP7B): c.2293G> A (p.Asp765Asn)SNVPathogenic/ Likely pathogenicrs28942075GRCh37Chr 13, 52532509: 52532509
116ATP7BNM_ 000053.3(ATP7B): c.2827G> A (p.Gly943Ser)SNVPathogenicrs28942076GRCh37Chr 13, 52523836: 52523836
117ATP7BNM_ 000053.3(ATP7B): c.2755C> G (p.Arg919Gly)SNVPathogenic/ Likely pathogenicrs121907993GRCh37Chr 13, 52523908: 52523908
118ATP7BATP7B, 1-BP DEL, 2511AdeletionPathogenic
119ATP7BNM_ 000053.3(ATP7B): c.2906G> A (p.Arg969Gln)SNVPathogenicrs121907996GRCh37Chr 13, 52520574: 52520574
120ATP7BNM_ 000053.3(ATP7B): c.2297C> G (p.Thr766Arg)SNVPathogenicrs121907997GRCh37Chr 13, 52532505: 52532505
121ATP7BNM_ 000053.3(ATP7B): c.1934T> G (p.Met645Arg)SNVPathogenicrs121907998GRCh37Chr 13, 52535985: 52535985
122ATP7BNM_ 000053.3(ATP7B): c.865C> T (p.Gln289Ter)SNVPathogenic/ Likely pathogenicrs121907999GRCh37Chr 13, 52548491: 52548491
123ATP7BNM_ 000053.3(ATP7B): c.2123T> C (p.Leu708Pro)SNVPathogenicrs121908000GRCh37Chr 13, 52532679: 52532679
124ATP7BNM_ 000053.3(ATP7B): c.2071G> A (p.Gly691Arg)SNVPathogenic/ Likely pathogenicrs121908001GRCh37Chr 13, 52534334: 52534334
125ATP7BNM_ 000053.3(ATP7B): c.1374_ 1377delAGTG (p.Val459Leufs)deletionLikely pathogenicrs1060499593GRCh38Chr 13, 51970658: 51970661
126ATP7BNM_ 000053.3(ATP7B): c.3236G> T (p.Cys1079Phe)SNVPathogenicGRCh38Chr 13, 51944116: 51944116
127ATP7BNM_ 000053.3(ATP7B): c.3402delC (p.Ala1135Glnfs)deletionPathogenicrs137853281GRCh37Chr 13, 52516532: 52516532
128ATP7BNM_ 000053.3(ATP7B): c.915T> A (p.Cys305Ter)SNVPathogenicrs398123137GRCh37Chr 13, 52548441: 52548441

Expression for genes affiliated with Wilson Disease

About this section
Search GEO for disease gene expression data for Wilson Disease.

Pathways for genes affiliated with Wilson Disease

About this section

Pathways related to Wilson Disease according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7ATP7A, ATP7B, SLC31A1
29.7ATP7A, ATP7B, SLC31A1
3
Show member pathways
9.4ATOX1, ATP7A, CAT
49.2ATOX1, ATP7A, SLC31A1, TF
59.1ATOX1, ATP7A, ATP7B, COMMD1, SLC31A1
6
Show member pathways
8.5ALB, ATP7A, ATP7B, CP, SLC31A1, TF

GO Terms for genes affiliated with Wilson Disease

About this section

Cellular components related to Wilson Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1basal part of cellGO:004517810.5HFE, TF
2HFE-transferrin receptor complexGO:199071210.4HFE, TF
3late endosomeGO:00057709.9ATP7A, ATP7B, SLC31A1, TF
4endoplasmic reticulum lumenGO:00057889.7ALB, CP, ESD, TF
5cytoplasmic vesicleGO:00314109.2ATP7B, COMMD1, DRD2, ESD, HFE, TF
6recycling endosomeGO:00550379.2COMMD1, HFE, SLC31A1, TF
7extracellular spaceGO:00056157.7ALB, CAT, CP, GPT, HFE, LOX

Biological processes related to Wilson Disease according to GeneCards Suite gene sharing:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1ATP hydrolysis coupled cation transmembrane transportGO:009913210.8ATP7A, ATP7B
2copper ion exportGO:006000310.8ATP7A, ATP7B
3response to copper ionGO:004668810.7ATP7A, ATP7B
4intracellular copper ion transportGO:001568010.7ATOX1, ATP7B
5positive regulation of receptor-mediated endocytosisGO:004826010.5HFE, TF
6response to lead ionGO:001028810.5ATP7A, CAT
7dopamine metabolic processGO:004241710.5ATP7A, DRD2
8copper ion importGO:001567710.5ATP7A, ATP7B, SLC31A1
9metal ion transportGO:003000110.4ATOX1, ATP7A, ATP7B
10response to iron ionGO:001003910.4DRD2, HFE
11copper ion transmembrane transportGO:003543410.4ATOX1, ATP7B, SLC31A1
12cellular iron ion homeostasisGO:000687910.3CP, HFE, TF
13cellular response to iron ionGO:007128110.3ATP7A, HFE, TF
14response to inactivityGO:001485410.2CAT, DRD2
15elastic fiber assemblyGO:004825110.2ATP7A, LOX
16cellular copper ion homeostasisGO:000687810.1ATOX1, ATP7A, ATP7B, SLC31A1
17copper ion transportGO:00068259.9ATOX1, ATP7A, ATP7B, CP, SLC31A1
18post-translational protein modificationGO:00436879.7ALB, COMMD1, CP, TF
19ion transportGO:00068119.2ATOX1, ATP7A, ATP7B, CP, HFE, SLC31A1
20transportGO:00068107.5ALB, ATOX1, ATP7A, ATP7B, COMMD1, CP

Molecular functions related to Wilson Disease according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1cation-transporting ATPase activityGO:001982910.8ATP7A, ATP7B
2copper-exporting ATPase activityGO:000400810.8ATP7A, ATP7B
3copper-dependent protein bindingGO:003276710.7ATOX1, ATP7A
4antioxidant activityGO:001620910.2ALB, CAT
5chaperone bindingGO:005108710.1ALB, ATP7A, CP
6copper ion transmembrane transporter activityGO:000537510.1ATOX1, ATP7A, ATP7B, SLC31A1
7transferrin receptor bindingGO:19904599.8HFE, TF
8copper ion bindingGO:00055078.5ALB, ATOX1, ATP7A, ATP7B, COMMD1, CP
9metal ion bindingGO:00468727.1ALB, ATOX1, ATP7A, ATP7B, CAT, COMMD1

Sources for Wilson Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet